Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for WRNIP1
Z-value: 1.89
Motif logo
Transcription factors associated with WRNIP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
WRNIP1
|
ENSG00000124535.11 | WRN helicase interacting protein 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| WRNIP1 | hg19_v2_chr6_+_2765595_2765797 | -0.24 | 2.1e-01 | Click! |
Activity profile of WRNIP1 motif
Sorted Z-values of WRNIP1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_51471381 | 22.81 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51504852 | 20.97 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
| chr19_-_51471362 | 19.12 |
ENST00000376853.4
ENST00000424910.2 |
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51472031 | 16.42 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51466681 | 14.26 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_+_35645817 | 13.12 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr19_+_35645618 | 13.00 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr19_-_51456344 | 12.95 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
| chr19_-_51487282 | 11.62 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
| chr19_-_51504411 | 11.27 |
ENST00000593490.1
|
KLK8
|
kallikrein-related peptidase 8 |
| chr19_-_51487071 | 10.34 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
| chr1_-_205391178 | 10.12 |
ENST00000367153.4
ENST00000367151.2 ENST00000391936.2 ENST00000367149.3 |
LEMD1
|
LEM domain containing 1 |
| chr19_-_51456321 | 9.88 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
| chr19_-_51472823 | 9.64 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51472222 | 8.98 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
| chr8_-_7274385 | 8.78 |
ENST00000318157.2
|
DEFB4B
|
defensin, beta 4B |
| chr8_-_23261589 | 8.70 |
ENST00000524168.1
ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2
|
lysyl oxidase-like 2 |
| chr19_-_51845378 | 8.08 |
ENST00000335624.4
|
VSIG10L
|
V-set and immunoglobulin domain containing 10 like |
| chr7_+_157318477 | 7.69 |
ENST00000444154.1
|
AC006372.1
|
AC006372.1 |
| chr1_-_205419053 | 7.64 |
ENST00000367154.1
|
LEMD1
|
LEM domain containing 1 |
| chr1_-_28503693 | 7.63 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
| chr7_-_41740181 | 7.06 |
ENST00000442711.1
|
INHBA
|
inhibin, beta A |
| chr12_-_25055949 | 6.56 |
ENST00000539282.1
|
BCAT1
|
branched chain amino-acid transaminase 1, cytosolic |
| chr19_-_51456198 | 6.33 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
| chr15_-_90039805 | 6.30 |
ENST00000544600.1
ENST00000268122.4 |
RHCG
|
Rh family, C glycoprotein |
| chr19_-_19051993 | 6.24 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chr20_+_33759854 | 5.96 |
ENST00000216968.4
|
PROCR
|
protein C receptor, endothelial |
| chr1_+_20915409 | 5.93 |
ENST00000375071.3
|
CDA
|
cytidine deaminase |
| chrX_-_38080077 | 5.86 |
ENST00000378533.3
ENST00000544439.1 ENST00000432886.2 ENST00000538295.1 |
SRPX
|
sushi-repeat containing protein, X-linked |
| chr19_-_19051927 | 5.73 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
| chr12_+_53491220 | 5.66 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
| chr2_-_31637560 | 5.65 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
| chr1_+_32042131 | 5.64 |
ENST00000271064.7
ENST00000537531.1 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
| chr1_-_20812690 | 5.55 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chr18_+_47088401 | 5.52 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
| chr19_-_55658281 | 5.47 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr1_-_204116078 | 5.31 |
ENST00000367198.2
ENST00000452983.1 |
ETNK2
|
ethanolamine kinase 2 |
| chr19_-_51014345 | 5.28 |
ENST00000391815.3
ENST00000594350.1 ENST00000601423.1 |
JOSD2
|
Josephin domain containing 2 |
| chr14_-_94443105 | 5.11 |
ENST00000555019.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
| chr19_-_51537982 | 4.98 |
ENST00000525263.1
|
KLK12
|
kallikrein-related peptidase 12 |
| chr16_-_84651673 | 4.98 |
ENST00000262428.4
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
| chrX_-_107019181 | 4.96 |
ENST00000315660.4
ENST00000372384.2 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family, member 3 |
| chr19_+_38826477 | 4.87 |
ENST00000409410.2
ENST00000215069.4 |
CATSPERG
|
catsper channel auxiliary subunit gamma |
| chr19_-_36019123 | 4.83 |
ENST00000588674.1
ENST00000452271.2 ENST00000518157.1 |
SBSN
|
suprabasin |
| chr19_-_51014460 | 4.82 |
ENST00000595669.1
|
JOSD2
|
Josephin domain containing 2 |
| chr1_-_24469602 | 4.78 |
ENST00000270800.1
|
IL22RA1
|
interleukin 22 receptor, alpha 1 |
| chr8_+_7752151 | 4.76 |
ENST00000302247.2
|
DEFB4A
|
defensin, beta 4A |
| chr20_-_52790055 | 4.75 |
ENST00000395955.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
| chr2_-_113594279 | 4.74 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
| chr9_+_33795533 | 4.65 |
ENST00000379405.3
|
PRSS3
|
protease, serine, 3 |
| chr22_+_38071615 | 4.64 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
| chr11_-_123065989 | 4.60 |
ENST00000448775.2
|
CLMP
|
CXADR-like membrane protein |
| chr22_+_31488433 | 4.45 |
ENST00000455608.1
|
SMTN
|
smoothelin |
| chr20_-_52790512 | 4.41 |
ENST00000216862.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
| chr2_+_64681219 | 4.39 |
ENST00000238875.5
|
LGALSL
|
lectin, galactoside-binding-like |
| chr6_-_30654977 | 4.39 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
| chr17_+_39969183 | 4.35 |
ENST00000321562.4
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
| chr6_+_151561506 | 4.34 |
ENST00000253332.1
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr19_+_54371114 | 4.32 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
| chr2_+_228678550 | 4.29 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
| chr6_+_151561085 | 4.27 |
ENST00000402676.2
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr11_-_111783595 | 4.25 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
| chr5_-_127873659 | 4.19 |
ENST00000262464.4
|
FBN2
|
fibrillin 2 |
| chr12_+_8975061 | 4.17 |
ENST00000299698.7
|
A2ML1
|
alpha-2-macroglobulin-like 1 |
| chr8_+_22022800 | 4.15 |
ENST00000397814.3
|
BMP1
|
bone morphogenetic protein 1 |
| chr14_-_94421923 | 4.11 |
ENST00000555507.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
| chr1_+_32042105 | 4.08 |
ENST00000457433.2
ENST00000441210.2 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
| chr8_+_54793425 | 4.08 |
ENST00000522225.1
|
RGS20
|
regulator of G-protein signaling 20 |
| chr1_+_17531614 | 4.05 |
ENST00000375471.4
|
PADI1
|
peptidyl arginine deiminase, type I |
| chr4_-_57524061 | 4.03 |
ENST00000508121.1
|
HOPX
|
HOP homeobox |
| chr20_-_43280325 | 4.03 |
ENST00000537820.1
|
ADA
|
adenosine deaminase |
| chr1_+_150522222 | 4.03 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
| chr11_-_2160180 | 4.00 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr6_+_86159821 | 3.98 |
ENST00000369651.3
|
NT5E
|
5'-nucleotidase, ecto (CD73) |
| chr19_+_54926601 | 3.98 |
ENST00000301194.4
|
TTYH1
|
tweety family member 1 |
| chr8_+_54793454 | 3.97 |
ENST00000276500.4
|
RGS20
|
regulator of G-protein signaling 20 |
| chr6_+_150263136 | 3.95 |
ENST00000367351.3
|
ULBP2
|
UL16 binding protein 2 |
| chr7_+_100770328 | 3.94 |
ENST00000223095.4
ENST00000445463.2 |
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
| chr1_+_152957707 | 3.93 |
ENST00000368762.1
|
SPRR1A
|
small proline-rich protein 1A |
| chr15_-_74495188 | 3.92 |
ENST00000563965.1
ENST00000395105.4 |
STRA6
|
stimulated by retinoic acid 6 |
| chr9_+_125137565 | 3.91 |
ENST00000373698.5
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
| chr7_+_145813453 | 3.84 |
ENST00000361727.3
|
CNTNAP2
|
contactin associated protein-like 2 |
| chr12_-_57630873 | 3.83 |
ENST00000556732.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr4_-_57522470 | 3.82 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
| chrX_-_107018969 | 3.79 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
| chr3_-_13921594 | 3.77 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
| chr11_+_124735282 | 3.77 |
ENST00000397801.1
|
ROBO3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila) |
| chr4_-_175443484 | 3.77 |
ENST00000514584.1
ENST00000542498.1 ENST00000296521.7 ENST00000422112.2 ENST00000504433.1 |
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| chr15_-_75017711 | 3.75 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
| chr5_-_149682447 | 3.75 |
ENST00000328668.7
|
ARSI
|
arylsulfatase family, member I |
| chr14_-_75079026 | 3.73 |
ENST00000261978.4
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
| chr19_-_36004543 | 3.72 |
ENST00000339686.3
ENST00000447113.2 ENST00000440396.1 |
DMKN
|
dermokine |
| chr19_-_11689752 | 3.72 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr1_-_153521597 | 3.71 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
| chr16_-_84651647 | 3.67 |
ENST00000564057.1
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
| chr12_-_47473425 | 3.67 |
ENST00000550413.1
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr19_+_917287 | 3.64 |
ENST00000592648.1
ENST00000234371.5 |
KISS1R
|
KISS1 receptor |
| chr6_+_86159765 | 3.63 |
ENST00000369646.3
ENST00000257770.3 |
NT5E
|
5'-nucleotidase, ecto (CD73) |
| chr17_+_4736627 | 3.62 |
ENST00000355280.6
ENST00000347992.7 |
MINK1
|
misshapen-like kinase 1 |
| chr17_+_7942424 | 3.61 |
ENST00000573359.1
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
| chr17_+_42081914 | 3.60 |
ENST00000293404.3
ENST00000589767.1 |
NAGS
|
N-acetylglutamate synthase |
| chr21_-_28217721 | 3.60 |
ENST00000284984.3
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
| chr1_-_113498616 | 3.58 |
ENST00000433570.4
ENST00000538576.1 ENST00000458229.1 |
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
| chr19_+_51152702 | 3.57 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
| chr12_+_4382917 | 3.56 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
| chr19_+_45409011 | 3.55 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
| chr20_-_44540686 | 3.52 |
ENST00000477313.1
ENST00000542937.1 ENST00000372431.3 ENST00000354050.4 ENST00000420868.2 |
PLTP
|
phospholipid transfer protein |
| chr6_+_151662815 | 3.52 |
ENST00000359755.5
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr2_+_210288760 | 3.52 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
| chr1_+_203651937 | 3.52 |
ENST00000341360.2
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
| chr9_+_128509624 | 3.49 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr5_+_7654057 | 3.49 |
ENST00000537121.1
|
ADCY2
|
adenylate cyclase 2 (brain) |
| chr7_-_24797032 | 3.48 |
ENST00000409970.1
ENST00000409775.3 |
DFNA5
|
deafness, autosomal dominant 5 |
| chr11_+_125496619 | 3.46 |
ENST00000532669.1
ENST00000278916.3 |
CHEK1
|
checkpoint kinase 1 |
| chr13_+_110959598 | 3.45 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
| chr1_-_153029980 | 3.43 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
| chr11_-_66675371 | 3.43 |
ENST00000393955.2
|
PC
|
pyruvate carboxylase |
| chr2_-_70780572 | 3.39 |
ENST00000450929.1
|
TGFA
|
transforming growth factor, alpha |
| chr1_-_93426998 | 3.38 |
ENST00000370310.4
|
FAM69A
|
family with sequence similarity 69, member A |
| chr10_+_88718397 | 3.38 |
ENST00000372017.3
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr16_+_55512742 | 3.38 |
ENST00000568715.1
ENST00000219070.4 |
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
| chr2_-_216300784 | 3.37 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
| chr17_-_43209862 | 3.36 |
ENST00000322765.5
|
PLCD3
|
phospholipase C, delta 3 |
| chr19_+_39687596 | 3.36 |
ENST00000339852.4
|
NCCRP1
|
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) |
| chr7_-_93519471 | 3.35 |
ENST00000451238.1
|
TFPI2
|
tissue factor pathway inhibitor 2 |
| chr12_-_54813229 | 3.35 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
| chr16_-_85784557 | 3.34 |
ENST00000602675.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
| chr11_-_2158507 | 3.33 |
ENST00000381392.1
ENST00000381395.1 ENST00000418738.2 |
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr17_+_40610862 | 3.33 |
ENST00000393829.2
ENST00000546249.1 ENST00000537728.1 ENST00000264649.6 ENST00000585525.1 ENST00000343619.4 ENST00000544137.1 ENST00000589727.1 ENST00000587824.1 |
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1 |
| chr19_-_51014588 | 3.32 |
ENST00000598418.1
|
JOSD2
|
Josephin domain containing 2 |
| chr2_+_233925064 | 3.31 |
ENST00000359570.5
ENST00000538935.1 |
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
| chr19_-_51538148 | 3.30 |
ENST00000319590.4
ENST00000250351.4 |
KLK12
|
kallikrein-related peptidase 12 |
| chr19_-_51327034 | 3.29 |
ENST00000301420.2
ENST00000448701.2 |
KLK1
|
kallikrein 1 |
| chrX_-_48328631 | 3.28 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
| chr8_-_21999362 | 3.28 |
ENST00000334530.5
ENST00000518664.1 |
REEP4
|
receptor accessory protein 4 |
| chr7_+_40174565 | 3.26 |
ENST00000309930.5
ENST00000401647.2 ENST00000335693.4 ENST00000413931.1 ENST00000416370.1 ENST00000540834.1 |
C7orf10
|
succinylCoA:glutarate-CoA transferase |
| chr10_+_88718314 | 3.25 |
ENST00000348795.4
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr1_-_113478603 | 3.25 |
ENST00000443580.1
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
| chr5_+_150400124 | 3.24 |
ENST00000388825.4
ENST00000521650.1 ENST00000517973.1 |
GPX3
|
glutathione peroxidase 3 (plasma) |
| chr8_-_133097902 | 3.24 |
ENST00000262283.5
|
OC90
|
Otoconin-90 |
| chr7_+_100547156 | 3.21 |
ENST00000379458.4
|
MUC3A
|
Protein LOC100131514 |
| chr19_+_45281118 | 3.21 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chrX_-_48325857 | 3.21 |
ENST00000376875.1
|
SLC38A5
|
solute carrier family 38, member 5 |
| chrX_+_41192595 | 3.20 |
ENST00000399959.2
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked |
| chr9_+_35829208 | 3.18 |
ENST00000439587.2
ENST00000377991.4 |
TMEM8B
|
transmembrane protein 8B |
| chr1_-_153521714 | 3.17 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
| chr19_-_55658687 | 3.16 |
ENST00000593046.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr16_+_66638003 | 3.14 |
ENST00000562357.1
ENST00000360086.4 ENST00000562707.1 ENST00000361909.4 ENST00000460097.1 ENST00000565666.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr4_-_57547454 | 3.13 |
ENST00000556376.2
|
HOPX
|
HOP homeobox |
| chr4_-_80994619 | 3.12 |
ENST00000404191.1
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr14_+_24867992 | 3.12 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
| chr9_-_123639304 | 3.11 |
ENST00000436309.1
|
PHF19
|
PHD finger protein 19 |
| chr15_-_74504597 | 3.11 |
ENST00000416286.3
|
STRA6
|
stimulated by retinoic acid 6 |
| chr3_-_98620500 | 3.10 |
ENST00000326840.6
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
| chr9_+_128509663 | 3.09 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr1_-_17307173 | 3.09 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
| chr22_+_30792846 | 3.09 |
ENST00000312932.9
ENST00000428195.1 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr15_-_74504560 | 3.08 |
ENST00000449139.2
|
STRA6
|
stimulated by retinoic acid 6 |
| chr19_-_36001286 | 3.08 |
ENST00000602679.1
ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN
|
dermokine |
| chr19_+_38826415 | 3.08 |
ENST00000410018.1
ENST00000409235.3 |
CATSPERG
|
catsper channel auxiliary subunit gamma |
| chr4_-_175443788 | 3.07 |
ENST00000541923.1
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| chr10_+_75670862 | 3.06 |
ENST00000446342.1
ENST00000372764.3 ENST00000372762.4 |
PLAU
|
plasminogen activator, urokinase |
| chr2_-_241396131 | 3.06 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
| chr19_-_51512804 | 3.06 |
ENST00000594211.1
ENST00000376832.4 |
KLK9
|
kallikrein-related peptidase 9 |
| chr17_-_36981556 | 3.03 |
ENST00000536127.1
ENST00000225428.5 |
CWC25
|
CWC25 spliceosome-associated protein homolog (S. cerevisiae) |
| chr19_-_51538118 | 3.03 |
ENST00000529888.1
|
KLK12
|
kallikrein-related peptidase 12 |
| chr2_+_113816685 | 3.03 |
ENST00000393200.2
|
IL36RN
|
interleukin 36 receptor antagonist |
| chr2_-_42991257 | 3.02 |
ENST00000378661.2
|
OXER1
|
oxoeicosanoid (OXE) receptor 1 |
| chr19_-_43269809 | 3.01 |
ENST00000406636.3
ENST00000404209.4 ENST00000306511.4 |
PSG8
|
pregnancy specific beta-1-glycoprotein 8 |
| chr16_-_85784718 | 3.00 |
ENST00000602766.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
| chr9_+_34653861 | 3.00 |
ENST00000556792.1
ENST00000318041.9 ENST00000378817.4 |
IL11RA
|
interleukin 11 receptor, alpha |
| chr2_+_95691445 | 2.99 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
| chr19_-_51017881 | 2.99 |
ENST00000601207.1
ENST00000598657.1 ENST00000376916.3 |
ASPDH
|
aspartate dehydrogenase domain containing |
| chr2_+_64681103 | 2.97 |
ENST00000464281.1
|
LGALSL
|
lectin, galactoside-binding-like |
| chr15_+_63335899 | 2.97 |
ENST00000561266.1
|
TPM1
|
tropomyosin 1 (alpha) |
| chr14_-_23834411 | 2.96 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
| chr9_-_21305312 | 2.94 |
ENST00000259555.4
|
IFNA5
|
interferon, alpha 5 |
| chr12_+_119616447 | 2.93 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
| chr19_-_42916499 | 2.93 |
ENST00000601189.1
ENST00000599211.1 |
LIPE
|
lipase, hormone-sensitive |
| chr1_+_152486950 | 2.93 |
ENST00000368790.3
|
CRCT1
|
cysteine-rich C-terminal 1 |
| chr17_+_40704938 | 2.93 |
ENST00000225929.5
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1 |
| chr22_-_37640456 | 2.91 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr15_+_63481668 | 2.91 |
ENST00000321437.4
ENST00000559006.1 ENST00000448330.2 |
RAB8B
|
RAB8B, member RAS oncogene family |
| chr3_+_47324424 | 2.90 |
ENST00000437353.1
ENST00000232766.5 ENST00000455924.2 |
KLHL18
|
kelch-like family member 18 |
| chr10_+_102106829 | 2.89 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
| chr15_-_74501360 | 2.88 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
| chr15_-_34659349 | 2.88 |
ENST00000314891.6
|
LPCAT4
|
lysophosphatidylcholine acyltransferase 4 |
| chr5_-_39219705 | 2.88 |
ENST00000351578.6
|
FYB
|
FYN binding protein |
| chr12_-_25055177 | 2.88 |
ENST00000538118.1
|
BCAT1
|
branched chain amino-acid transaminase 1, cytosolic |
| chr9_-_33167308 | 2.87 |
ENST00000535206.1
ENST00000379731.4 |
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
| chr2_-_208030647 | 2.86 |
ENST00000309446.6
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
| chr9_+_35673853 | 2.85 |
ENST00000378357.4
|
CA9
|
carbonic anhydrase IX |
| chr1_-_153013588 | 2.85 |
ENST00000360379.3
|
SPRR2D
|
small proline-rich protein 2D |
| chr17_-_76899275 | 2.85 |
ENST00000322630.2
ENST00000586713.1 |
DDC8
|
Protein DDC8 homolog |
| chr12_-_122238464 | 2.83 |
ENST00000546227.1
|
RHOF
|
ras homolog family member F (in filopodia) |
| chr5_-_60140009 | 2.83 |
ENST00000505959.1
|
ELOVL7
|
ELOVL fatty acid elongase 7 |
| chr12_+_4385230 | 2.83 |
ENST00000536537.1
|
CCND2
|
cyclin D2 |
| chr4_-_80994471 | 2.82 |
ENST00000295465.4
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr5_+_156887027 | 2.82 |
ENST00000435489.2
ENST00000311946.7 |
NIPAL4
|
NIPA-like domain containing 4 |
| chrX_-_48328551 | 2.81 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
Network of associatons between targets according to the STRING database.
First level regulatory network of WRNIP1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.5 | 51.0 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 8.3 | 24.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 4.3 | 94.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 3.9 | 31.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 3.8 | 11.4 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 3.5 | 14.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 3.2 | 9.6 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 3.1 | 9.4 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 3.0 | 5.9 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 2.9 | 8.6 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 2.7 | 13.4 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 2.5 | 4.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 2.4 | 9.4 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 2.3 | 6.9 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 2.3 | 6.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 2.1 | 6.2 | GO:2000283 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 2.0 | 2.0 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 2.0 | 8.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 2.0 | 12.0 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 1.9 | 5.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 1.8 | 1.8 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 1.8 | 1.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 1.8 | 10.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 1.8 | 5.3 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 1.6 | 4.9 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.6 | 1.6 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
| 1.6 | 6.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 1.6 | 6.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.6 | 7.8 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.5 | 4.6 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.5 | 9.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.5 | 4.5 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 1.5 | 13.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.5 | 4.5 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.5 | 5.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 1.5 | 7.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.5 | 8.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 1.5 | 4.4 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 1.4 | 7.1 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
| 1.4 | 4.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 1.4 | 1.4 | GO:0060516 | primary prostatic bud elongation(GO:0060516) |
| 1.4 | 4.2 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 1.4 | 4.1 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.4 | 1.4 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 1.4 | 6.9 | GO:0060301 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 1.4 | 5.5 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 1.3 | 6.7 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 1.3 | 6.6 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
| 1.3 | 5.3 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 1.3 | 6.6 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.3 | 10.5 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 1.3 | 3.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.3 | 5.2 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 1.3 | 3.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 1.3 | 5.1 | GO:2000685 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 1.3 | 1.3 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 1.2 | 1.2 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 1.2 | 1.2 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 1.2 | 4.9 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.2 | 4.9 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.2 | 2.4 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 1.2 | 6.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 1.2 | 30.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 1.2 | 1.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 1.2 | 1.2 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 1.2 | 4.7 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 1.2 | 5.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 1.1 | 1.1 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 1.1 | 2.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 1.1 | 3.4 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 1.1 | 1.1 | GO:0014015 | positive regulation of gliogenesis(GO:0014015) regulation of glial cell differentiation(GO:0045685) |
| 1.1 | 2.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) cellular response to growth hormone stimulus(GO:0071378) |
| 1.1 | 1.1 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
| 1.1 | 1.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 1.1 | 3.2 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.1 | 1.1 | GO:1901205 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 1.1 | 1.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 1.1 | 3.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 1.0 | 1.0 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) positive regulation of sperm motility(GO:1902093) |
| 1.0 | 1.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 1.0 | 2.1 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 1.0 | 7.3 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 1.0 | 3.1 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 1.0 | 9.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.0 | 4.1 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 1.0 | 3.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.0 | 5.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 1.0 | 6.0 | GO:0051012 | microtubule sliding(GO:0051012) |
| 1.0 | 10.0 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 1.0 | 6.0 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.0 | 1.0 | GO:1903202 | negative regulation of oxidative stress-induced cell death(GO:1903202) |
| 1.0 | 2.9 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 1.0 | 5.8 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 1.0 | 1.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 0.9 | 10.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.9 | 2.8 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.9 | 6.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.9 | 6.4 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.9 | 7.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.9 | 3.6 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 0.9 | 1.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.9 | 7.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.9 | 8.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.9 | 3.5 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.9 | 7.7 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.9 | 3.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.9 | 6.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.9 | 7.7 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.9 | 5.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.8 | 6.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.8 | 0.8 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.8 | 1.7 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.8 | 12.6 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.8 | 2.5 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.8 | 2.5 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
| 0.8 | 2.5 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.8 | 3.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.8 | 3.3 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.8 | 1.6 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 0.8 | 3.2 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.8 | 4.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.8 | 4.0 | GO:1990834 | response to odorant(GO:1990834) |
| 0.8 | 3.2 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.8 | 1.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.8 | 2.4 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 0.8 | 3.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.8 | 2.4 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.8 | 2.4 | GO:0030070 | insulin processing(GO:0030070) |
| 0.8 | 0.8 | GO:0090345 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.8 | 3.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.8 | 2.3 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.8 | 2.3 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.8 | 13.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.8 | 0.8 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
| 0.8 | 2.3 | GO:0043318 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.8 | 2.3 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 0.8 | 2.3 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.8 | 4.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.7 | 3.0 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.7 | 6.0 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.7 | 3.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.7 | 0.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.7 | 0.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.7 | 2.2 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.7 | 12.4 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.7 | 5.8 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.7 | 21.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.7 | 0.7 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
| 0.7 | 2.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.7 | 1.4 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 0.7 | 2.2 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.7 | 12.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.7 | 2.9 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.7 | 5.0 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.7 | 5.7 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.7 | 2.1 | GO:0048627 | myoblast development(GO:0048627) |
| 0.7 | 2.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.7 | 2.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.7 | 0.7 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.7 | 2.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.7 | 3.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.7 | 2.7 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.7 | 0.7 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.7 | 0.7 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.7 | 6.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.7 | 4.7 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.7 | 2.0 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.7 | 5.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
| 0.7 | 6.1 | GO:0046618 | drug export(GO:0046618) |
| 0.7 | 10.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.7 | 2.0 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.7 | 5.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.7 | 2.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.7 | 0.7 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.7 | 3.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.6 | 1.9 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.6 | 2.6 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.6 | 1.9 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.6 | 0.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.6 | 3.8 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.6 | 9.6 | GO:0001660 | fever generation(GO:0001660) |
| 0.6 | 1.9 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.6 | 5.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.6 | 1.9 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.6 | 0.6 | GO:1903923 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 0.6 | 1.9 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
| 0.6 | 4.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.6 | 2.5 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.6 | 5.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.6 | 3.7 | GO:0014028 | notochord formation(GO:0014028) |
| 0.6 | 0.6 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
| 0.6 | 1.2 | GO:0007622 | rhythmic behavior(GO:0007622) |
| 0.6 | 0.6 | GO:0045575 | basophil activation(GO:0045575) |
| 0.6 | 1.8 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.6 | 1.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.6 | 0.6 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
| 0.6 | 2.4 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.6 | 1.2 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
| 0.6 | 3.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.6 | 1.8 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.6 | 2.4 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.6 | 0.6 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.6 | 2.9 | GO:0060356 | leucine import(GO:0060356) |
| 0.6 | 6.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.6 | 5.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.6 | 6.9 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.6 | 2.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.6 | 1.7 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.6 | 1.7 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.6 | 5.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.6 | 1.1 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.6 | 2.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.6 | 9.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.6 | 1.1 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.6 | 2.3 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.6 | 0.6 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.6 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.6 | 0.6 | GO:0030432 | peristalsis(GO:0030432) |
| 0.6 | 7.9 | GO:0015816 | glycine transport(GO:0015816) |
| 0.6 | 1.1 | GO:1904640 | response to methionine(GO:1904640) |
| 0.6 | 9.4 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.6 | 1.1 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 0.6 | 2.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.5 | 2.7 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.5 | 2.2 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.5 | 0.5 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.5 | 6.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.5 | 1.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.5 | 2.2 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.5 | 10.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.5 | 1.6 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.5 | 9.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.5 | 3.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.5 | 1.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.5 | 2.7 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.5 | 2.1 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.5 | 0.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.5 | 3.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.5 | 2.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 0.5 | 1.6 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.5 | 2.6 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.5 | 3.2 | GO:0030421 | defecation(GO:0030421) |
| 0.5 | 1.6 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.5 | 2.6 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.5 | 2.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.5 | 1.6 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.5 | 1.6 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.5 | 3.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.5 | 2.6 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.5 | 1.6 | GO:1904351 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.5 | 12.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.5 | 4.7 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.5 | 4.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.5 | 1.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.5 | 6.7 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
| 0.5 | 7.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.5 | 2.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.5 | 1.0 | GO:0015820 | leucine transport(GO:0015820) |
| 0.5 | 3.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.5 | 2.0 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.5 | 0.5 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.5 | 2.0 | GO:0046671 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.5 | 4.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.5 | 0.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.5 | 1.5 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.5 | 2.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.5 | 4.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.5 | 2.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.5 | 1.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.5 | 5.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.5 | 1.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.5 | 1.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.5 | 1.5 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.5 | 5.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.5 | 3.4 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.5 | 5.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.5 | 1.9 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.5 | 1.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.5 | 2.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.5 | 1.0 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.5 | 1.4 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.5 | 6.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 | 3.8 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.5 | 6.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.5 | 1.4 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.5 | 0.9 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.5 | 1.4 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.5 | 2.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.5 | 1.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.5 | 2.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.5 | 1.4 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.5 | 0.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.5 | 1.4 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.5 | 0.5 | GO:0042161 | regulation of lipoprotein oxidation(GO:0034442) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.5 | 0.9 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.5 | 1.4 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.5 | 1.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.5 | 1.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
| 0.5 | 1.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.5 | 0.5 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
| 0.5 | 1.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.5 | 0.9 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.5 | 0.9 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.5 | 5.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.5 | 1.4 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.5 | 4.1 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.5 | 0.5 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.5 | 2.3 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 0.5 | 2.7 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.5 | 3.2 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.5 | 2.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.5 | 2.7 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.5 | 0.5 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.5 | 7.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.4 | 1.3 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.4 | 0.9 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.4 | 0.9 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.4 | 8.5 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.4 | 0.9 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.4 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 | 0.9 | GO:1902275 | regulation of chromatin organization(GO:1902275) |
| 0.4 | 0.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.4 | 1.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.4 | 2.2 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.4 | 11.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.4 | 3.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.4 | 4.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.4 | 1.8 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.4 | 1.3 | GO:0050894 | determination of affect(GO:0050894) |
| 0.4 | 1.8 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.4 | 0.9 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
| 0.4 | 5.3 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.4 | 2.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.4 | 0.9 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
| 0.4 | 3.1 | GO:0070305 | response to cGMP(GO:0070305) |
| 0.4 | 1.7 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.4 | 1.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.4 | 1.7 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.4 | 3.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.4 | 1.3 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.4 | 1.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.4 | 2.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 | 6.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.4 | 2.6 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.4 | 3.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.4 | 2.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.4 | 0.4 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
| 0.4 | 3.0 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.4 | 3.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.4 | 4.2 | GO:0030903 | notochord development(GO:0030903) |
| 0.4 | 1.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.4 | 0.8 | GO:0072376 | protein activation cascade(GO:0072376) |
| 0.4 | 5.0 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.4 | 0.4 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.4 | 1.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.4 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.4 | 2.1 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.4 | 0.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.4 | 2.1 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 | 1.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.4 | 0.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.4 | 1.7 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.4 | 0.8 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.4 | 1.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
| 0.4 | 1.2 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.4 | 1.6 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.4 | 1.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.4 | 5.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 | 3.3 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.4 | 1.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.4 | 1.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.4 | 2.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.4 | 3.2 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.4 | 2.0 | GO:0048749 | compound eye development(GO:0048749) |
| 0.4 | 1.6 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.4 | 0.4 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.4 | 2.4 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.4 | 2.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.4 | 0.8 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.4 | 0.8 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.4 | 0.4 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.4 | 0.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.4 | 2.0 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.4 | 3.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.4 | 0.8 | GO:0007219 | Notch signaling pathway(GO:0007219) |
| 0.4 | 3.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.4 | 1.2 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.4 | 1.2 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.4 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
| 0.4 | 0.4 | GO:0051604 | protein maturation(GO:0051604) |
| 0.4 | 4.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.4 | 1.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.4 | 1.6 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.4 | 2.3 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.4 | 0.4 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
| 0.4 | 5.8 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.4 | 3.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.4 | 4.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.4 | 7.7 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.4 | 1.2 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
| 0.4 | 0.4 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.4 | 1.5 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.4 | 4.6 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.4 | 1.5 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.4 | 0.8 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.4 | 4.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.4 | 9.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.4 | 1.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.4 | 4.2 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.4 | 1.5 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.4 | 0.8 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.4 | 1.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.4 | 0.4 | GO:0007272 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
| 0.4 | 0.4 | GO:0071706 | tumor necrosis factor superfamily cytokine production(GO:0071706) |
| 0.4 | 1.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 | 42.3 | GO:0070268 | cornification(GO:0070268) |
| 0.4 | 0.7 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.4 | 3.0 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.4 | 0.7 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.4 | 1.5 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.4 | 1.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.4 | 1.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.4 | 1.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.4 | 1.9 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.4 | 0.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.4 | 2.6 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.4 | 1.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.4 | 2.6 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.4 | 0.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.4 | 1.1 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 0.4 | 4.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) negative regulation of myoblast fusion(GO:1901740) |
| 0.4 | 3.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.4 | 0.4 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
| 0.4 | 2.2 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.4 | 1.1 | GO:0071726 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.4 | 3.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.4 | 6.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.4 | 1.8 | GO:0051775 | response to redox state(GO:0051775) |
| 0.4 | 2.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.4 | 3.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.4 | 8.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.4 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.4 | 3.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.4 | 1.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.4 | 0.7 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.4 | 1.1 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.4 | 1.8 | GO:1903243 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of lung blood pressure(GO:0061767) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.4 | 1.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.4 | 1.8 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.3 | 1.0 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.3 | 0.7 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.3 | 2.8 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.3 | 0.7 | GO:0017145 | stem cell division(GO:0017145) |
| 0.3 | 1.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.3 | 6.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.3 | 2.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.3 | 1.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.3 | 1.0 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.3 | 1.7 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.3 | 1.0 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
| 0.3 | 3.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.3 | 0.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
| 0.3 | 1.0 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.3 | 6.5 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.3 | 4.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 | 0.7 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.3 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.3 | 1.0 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.3 | 2.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.3 | 0.7 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.3 | 1.0 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.3 | 3.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 | 2.0 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.3 | 0.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.3 | 2.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.3 | 1.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.3 | 5.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 1.7 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.3 | 2.3 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.3 | 1.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.3 | 0.7 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.3 | 0.7 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.3 | 1.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.3 | 1.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.3 | 0.3 | GO:0035315 | hair cell differentiation(GO:0035315) |
| 0.3 | 1.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.3 | 4.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.3 | 0.7 | GO:1990641 | regulation of T cell antigen processing and presentation(GO:0002625) response to iron ion starvation(GO:1990641) |
| 0.3 | 5.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.3 | 4.0 | GO:0033622 | integrin activation(GO:0033622) |
| 0.3 | 2.0 | GO:0000050 | urea cycle(GO:0000050) |
| 0.3 | 1.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
| 0.3 | 2.3 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.3 | 5.6 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.3 | 3.0 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
| 0.3 | 0.7 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.3 | 2.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.3 | 6.9 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.3 | 1.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.3 | 3.3 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.3 | 0.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.3 | 2.6 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.3 | 0.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.3 | 1.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.3 | 0.6 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.3 | 1.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.3 | 1.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
| 0.3 | 0.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.3 | 0.3 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 0.3 | 0.3 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
| 0.3 | 0.6 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 0.3 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.3 | 1.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.3 | 10.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.3 | 1.6 | GO:0003068 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.3 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.3 | 1.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.3 | 6.5 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.3 | 0.6 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.3 | 1.2 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.3 | 0.9 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.3 | 0.6 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 0.3 | 0.3 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
| 0.3 | 3.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.3 | 0.3 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
| 0.3 | 0.3 | GO:0098868 | bone growth(GO:0098868) |
| 0.3 | 0.9 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.3 | 1.5 | GO:0097384 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) cellular lipid biosynthetic process(GO:0097384) |
| 0.3 | 1.2 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.3 | 0.3 | GO:0051938 | L-glutamate import(GO:0051938) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 0.3 | 3.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.3 | 2.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.3 | 4.5 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.3 | 7.8 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.3 | 0.9 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.3 | 1.2 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.3 | 0.6 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.3 | 0.6 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.3 | 0.6 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.3 | 0.9 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.3 | 1.5 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 0.9 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.3 | 0.3 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.3 | 0.9 | GO:0009629 | response to gravity(GO:0009629) |
| 0.3 | 0.3 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.3 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.3 | 3.9 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.3 | 3.6 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.3 | 0.3 | GO:0043200 | response to amino acid(GO:0043200) |
| 0.3 | 0.9 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.3 | 0.3 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.3 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.3 | 4.7 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.3 | 0.6 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
| 0.3 | 0.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.3 | 1.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.3 | 1.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.3 | 0.9 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.3 | 14.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.3 | 6.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.3 | 1.7 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
| 0.3 | 1.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.3 | 0.9 | GO:0007343 | egg activation(GO:0007343) |
| 0.3 | 0.6 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.3 | 1.2 | GO:0001757 | somite specification(GO:0001757) |
| 0.3 | 0.9 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.3 | 0.9 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.3 | 0.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.3 | 0.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.3 | 10.0 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.3 | 1.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.3 | 0.3 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.3 | 0.3 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.3 | 2.3 | GO:0046958 | nonassociative learning(GO:0046958) |
| 0.3 | 3.9 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.3 | 2.0 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
| 0.3 | 0.6 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.3 | 2.5 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.3 | 1.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 | 2.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.3 | 1.7 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.3 | 0.6 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.3 | 0.8 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.3 | 0.8 | GO:2000342 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.3 | 5.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.3 | 0.8 | GO:1904604 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.3 | 1.7 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.3 | 1.1 | GO:0046833 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.3 | 0.8 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.3 | 13.8 | GO:1901998 | toxin transport(GO:1901998) |
| 0.3 | 3.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.3 | 0.3 | GO:0060266 | respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.3 | 0.8 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
| 0.3 | 1.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.3 | 0.3 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.3 | 3.3 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.3 | 1.4 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.3 | 1.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.3 | 1.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.3 | 0.8 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.3 | 7.3 | GO:0097435 | fibril organization(GO:0097435) |
| 0.3 | 0.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.3 | 1.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 | 1.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.3 | 1.1 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.3 | 0.3 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
| 0.3 | 0.8 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.3 | 2.7 | GO:0015074 | DNA integration(GO:0015074) |
| 0.3 | 0.8 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.3 | 1.9 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.3 | 0.8 | GO:0035564 | regulation of kidney size(GO:0035564) |
| 0.3 | 0.8 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
| 0.3 | 0.8 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.3 | 0.5 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.3 | 0.5 | GO:0033260 | nuclear DNA replication(GO:0033260) cell cycle DNA replication(GO:0044786) |
| 0.3 | 1.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.3 | 1.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 | 0.3 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.3 | 0.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.3 | 0.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.3 | 0.5 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.3 | 1.6 | GO:0030578 | PML body organization(GO:0030578) |
| 0.3 | 0.3 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.3 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.3 | 0.8 | GO:1904478 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) regulation of intestinal absorption(GO:1904478) negative regulation of intestinal absorption(GO:1904479) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.3 | 0.8 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.3 | 1.8 | GO:0015840 | urea transport(GO:0015840) |
| 0.3 | 1.0 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.3 | 0.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.3 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.3 | 1.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.3 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.3 | 1.0 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.3 | 1.5 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.3 | 0.3 | GO:0070231 | T cell apoptotic process(GO:0070231) |
| 0.3 | 1.5 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.3 | 0.8 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.3 | 1.0 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.3 | 0.8 | GO:0051685 | maintenance of ER location(GO:0051685) |
| 0.3 | 2.6 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.3 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.3 | 1.5 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.3 | 1.3 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.3 | 0.8 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.3 | 1.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 | 0.3 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
| 0.3 | 0.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.3 | 1.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.3 | 0.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.3 | 1.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.3 | 1.0 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.3 | 1.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 | 0.3 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
| 0.2 | 0.5 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.2 | 2.5 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.2 | 1.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 | 2.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.2 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.2 | 1.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 | 0.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.2 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.2 | 0.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.2 | 2.0 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 8.3 | GO:0097503 | sialylation(GO:0097503) |
| 0.2 | 0.7 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
| 0.2 | 0.5 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.2 | 2.7 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 | 0.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.2 | 0.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.2 | 1.0 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.2 | 1.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.2 | 0.5 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.2 | 0.5 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
| 0.2 | 1.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 1.0 | GO:0030047 | actin modification(GO:0030047) |
| 0.2 | 1.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.2 | 0.5 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.2 | 1.7 | GO:0060872 | semicircular canal development(GO:0060872) |
| 0.2 | 1.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 | 1.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.2 | 1.0 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
| 0.2 | 0.7 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
| 0.2 | 2.4 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 | 0.7 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.2 | 0.2 | GO:0007530 | sex determination(GO:0007530) |
| 0.2 | 2.9 | GO:2000404 | regulation of T cell migration(GO:2000404) |
| 0.2 | 0.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.2 | 1.2 | GO:0008037 | cell recognition(GO:0008037) |
| 0.2 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.2 | 1.2 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.2 | 1.0 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 | 0.5 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.2 | 3.8 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.2 | 0.2 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.2 | 0.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.2 | 0.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 | 0.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
| 0.2 | 0.2 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.2 | 0.2 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.2 | 0.7 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.2 | 0.5 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.2 | 0.7 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.2 | 1.2 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.2 | 2.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.2 | 0.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 | 0.5 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.2 | 15.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.2 | 1.2 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.2 | 0.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.2 | 1.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.2 | 1.6 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.2 | 2.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 | 0.7 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.2 | 1.8 | GO:0015705 | iodide transport(GO:0015705) |
| 0.2 | 0.5 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.2 | 0.2 | GO:0046351 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) disaccharide biosynthetic process(GO:0046351) |
| 0.2 | 0.7 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
| 0.2 | 2.5 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.2 | 0.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 | 0.9 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 | 3.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.2 | 0.2 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
| 0.2 | 0.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.2 | 2.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.2 | 0.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.2 | 0.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.2 | 2.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.2 | 2.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 0.4 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.2 | 1.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.2 | 1.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.2 | 0.2 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.2 | 1.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 2.4 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 0.2 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.2 | 1.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 0.7 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.2 | 2.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.2 | 0.2 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.2 | 0.7 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.2 | 0.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.2 | 2.0 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.2 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.2 | 1.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.2 | 1.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.2 | 0.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.2 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 | 2.6 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.2 | 0.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.2 | 0.6 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
| 0.2 | 0.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.2 | 0.9 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
| 0.2 | 0.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 | 0.2 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.2 | 0.4 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.2 | 0.6 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.2 | 0.4 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.2 | 1.3 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.2 | 0.9 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.2 | 0.4 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.2 | 0.8 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.2 | 0.6 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.2 | 0.8 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 | 0.2 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.2 | 2.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.2 | 1.3 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.2 | 3.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.2 | 0.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 | 0.4 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.2 | 0.4 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.2 | 0.2 | GO:0007492 | endoderm development(GO:0007492) |
| 0.2 | 0.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.2 | 1.3 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
| 0.2 | 0.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 | 4.8 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.2 | 1.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.2 | 0.4 | GO:0050767 | regulation of neurogenesis(GO:0050767) |
| 0.2 | 0.2 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
| 0.2 | 2.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
| 0.2 | 0.6 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.2 | 0.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.2 | 2.5 | GO:0048265 | response to pain(GO:0048265) |
| 0.2 | 0.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.2 | 0.4 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.2 | 0.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.2 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 | 0.6 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
| 0.2 | 0.6 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 | 3.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 | 0.6 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
| 0.2 | 0.8 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.2 | 1.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 | 1.0 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 | 1.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
| 0.2 | 0.4 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.2 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.2 | 1.0 | GO:0008356 | asymmetric cell division(GO:0008356) |
| 0.2 | 0.6 | GO:0003383 | apical constriction(GO:0003383) |
| 0.2 | 0.8 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.2 | 1.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.2 | 1.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.2 | 1.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 0.2 | 2.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 1.8 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.2 | 0.8 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.2 | 1.6 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.2 | 4.7 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.2 | 1.0 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.2 | 0.4 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
| 0.2 | 1.6 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.2 | 1.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 0.2 | 1.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.2 | 0.8 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.2 | 0.6 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.2 | 1.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.2 | 2.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 0.6 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.2 | 0.4 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 | 1.9 | GO:0060068 | vagina development(GO:0060068) |
| 0.2 | 0.8 | GO:0001964 | startle response(GO:0001964) |
| 0.2 | 0.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 | 0.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.2 | 0.6 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.2 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
| 0.2 | 1.9 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.2 | 0.4 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.2 | 0.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.2 | 0.6 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.2 | 1.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.2 | 1.3 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.2 | 1.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.2 | 1.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 | 6.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 | 0.7 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.2 | 2.1 | GO:0048535 | lymph node development(GO:0048535) |
| 0.2 | 0.7 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 | 0.9 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.2 | 2.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.2 | 1.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 | 0.9 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.2 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.2 | 0.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 | 1.1 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
| 0.2 | 0.2 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.2 | 1.1 | GO:0048511 | rhythmic process(GO:0048511) |
| 0.2 | 0.7 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 1.3 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.2 | 0.4 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.2 | 1.1 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) |
| 0.2 | 0.4 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.2 | 1.5 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.2 | 0.6 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.2 | 0.5 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.2 | 0.5 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.2 | 0.9 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.2 | 1.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 | 0.5 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.2 | 0.7 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 0.2 | 0.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) asymmetric stem cell division(GO:0098722) |
| 0.2 | 0.5 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
| 0.2 | 0.9 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 | 0.4 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) |
| 0.2 | 0.9 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 | 0.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.2 | 0.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.2 | 0.5 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.2 | 0.9 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
| 0.2 | 0.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 0.9 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.2 | 0.7 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
| 0.2 | 0.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.2 | 0.5 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.2 | 0.2 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.2 | 0.9 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.2 | 1.8 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.2 | 0.5 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.2 | 0.5 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.2 | 0.2 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
| 0.2 | 8.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.2 | 1.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 | 0.5 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.2 | 3.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.2 | 4.2 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.2 | 0.5 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.2 | 0.9 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.2 | 0.2 | GO:0048536 | spleen development(GO:0048536) |
| 0.2 | 1.2 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.2 | 1.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.2 | 4.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.2 | 1.6 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
| 0.2 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.2 | 1.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.2 | 0.5 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 | 0.9 | GO:0044062 | regulation of excretion(GO:0044062) |
| 0.2 | 0.9 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
| 0.2 | 2.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.2 | 0.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.2 | 0.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.2 | 1.0 | GO:0040007 | growth(GO:0040007) |
| 0.2 | 0.3 | GO:0071362 | cellular response to ether(GO:0071362) |
| 0.2 | 0.7 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.2 | 0.3 | GO:1902568 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.2 | 6.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.2 | 0.9 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.2 | 7.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.2 | 0.2 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 | 0.7 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.2 | 2.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.2 | 0.2 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.2 | 1.2 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.2 | 0.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.2 | 0.3 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.2 | 2.0 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.2 | 0.2 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.2 | 0.5 | GO:0001207 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.2 | 0.8 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.2 | 0.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 | 1.7 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.2 | 0.3 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.2 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.2 | 1.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.2 | 1.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 | 1.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.2 | 0.5 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.2 | 2.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.2 | 1.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.2 | 0.8 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.2 | 9.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.2 | 0.3 | GO:0010193 | response to ozone(GO:0010193) |
| 0.2 | 4.0 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.2 | 1.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.2 | 5.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.2 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 | 0.7 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.2 | 0.5 | GO:0015879 | carnitine transport(GO:0015879) |
| 0.2 | 0.3 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.2 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.2 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.2 | 0.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.2 | 0.7 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.2 | 0.2 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
| 0.2 | 2.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.2 | 0.5 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.2 | 0.8 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.2 | 0.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 | 0.2 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.2 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) peptidyl-cysteine oxidation(GO:0018171) |
| 0.2 | 0.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
| 0.2 | 1.1 | GO:0051597 | response to methylmercury(GO:0051597) |
| 0.2 | 0.8 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
| 0.2 | 2.2 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.2 | 0.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.2 | 1.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 | 0.5 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.2 | 2.5 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
| 0.2 | 1.4 | GO:0060065 | uterus development(GO:0060065) |
| 0.2 | 3.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.2 | 0.3 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 0.2 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 | 0.9 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
| 0.2 | 0.3 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.2 | 0.2 | GO:0051940 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 0.2 | 0.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.2 | 0.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.2 | 1.2 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.2 | 0.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.2 | 0.2 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
| 0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 | 2.0 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.2 | 0.5 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
| 0.2 | 0.6 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
| 0.2 | 3.2 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.2 | 0.3 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.2 | 0.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 | 2.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.2 | 0.5 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.2 | 0.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 | 1.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.2 | 1.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.2 | 1.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.2 | 0.2 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
| 0.2 | 0.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.2 | 0.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 | 0.2 | GO:0060723 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 | 0.6 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.1 | 0.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 0.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 | 0.1 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
| 0.1 | 3.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 0.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 | 0.4 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.1 | 0.3 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
| 0.1 | 0.9 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 | 0.4 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.1 | 0.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 0.1 | 8.6 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
| 0.1 | 1.0 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.1 | 1.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 | 0.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 2.4 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 1.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 1.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.1 | 1.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 | 0.6 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
| 0.1 | 0.9 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.1 | 1.5 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.4 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 | 2.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.1 | 0.3 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 | 1.9 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 | 0.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.1 | 0.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.1 | 0.9 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 | 0.6 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 | 0.3 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.1 | 1.6 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
| 0.1 | 0.4 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 0.1 | 1.3 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 | 3.4 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 0.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 | 0.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 | 0.4 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.1 | 0.7 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 | 0.3 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 | 0.8 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 2.9 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.1 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 | 0.7 | GO:0060674 | placenta blood vessel development(GO:0060674) |
| 0.1 | 0.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.1 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.1 | 0.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.1 | 0.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.4 | GO:0006612 | protein targeting to membrane(GO:0006612) |
| 0.1 | 0.4 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 | 0.1 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.1 | 5.8 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.1 | 0.4 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 0.4 | GO:0071789 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.1 | 0.6 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 | 0.7 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 | 0.8 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.1 | 0.5 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.1 | 1.1 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.1 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
| 0.1 | 0.3 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.1 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.1 | 0.7 | GO:0015862 | uridine transport(GO:0015862) |
| 0.1 | 0.4 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.1 | 0.4 | GO:0010212 | response to ionizing radiation(GO:0010212) |
| 0.1 | 0.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 1.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.1 | 0.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.1 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 | 0.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 20.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 | 0.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 5.2 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 | 0.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 | 0.3 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.1 | 0.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.1 | 4.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.1 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.1 | 0.8 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 | 0.4 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 | 0.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 5.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 1.1 | GO:0046078 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 0.1 | 0.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.1 | 6.0 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 0.3 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 | 0.5 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 | 0.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.1 | 0.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 | 0.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
| 0.1 | 0.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.1 | 0.7 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.1 | 0.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 1.4 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.1 | 2.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.1 | 0.6 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 0.1 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.1 | 0.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.1 | 0.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 | 0.1 | GO:0051262 | protein tetramerization(GO:0051262) |
| 0.1 | 0.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 1.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.5 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
| 0.1 | 1.2 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 0.2 | GO:0008050 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
| 0.1 | 0.2 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 | 0.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.1 | 0.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.1 | 0.5 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
| 0.1 | 1.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.1 | 0.2 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.1 | 0.9 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.1 | 0.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 1.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 2.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
| 0.1 | 0.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.1 | 0.2 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.1 | 0.1 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 0.1 | 0.4 | GO:0021554 | optic nerve development(GO:0021554) |
| 0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 | 0.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.1 | 0.5 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
| 0.1 | 0.2 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
| 0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 4.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.1 | 0.4 | GO:0042596 | fear response(GO:0042596) |
| 0.1 | 0.6 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
| 0.1 | 1.5 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.1 | 0.9 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 0.8 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.4 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
| 0.1 | 0.2 | GO:0051294 | establishment of spindle orientation(GO:0051294) |
| 0.1 | 1.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.5 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 0.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 | 0.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
| 0.1 | 0.2 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 0.1 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 | 0.1 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
| 0.1 | 0.1 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.1 | 0.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 2.9 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 | 0.6 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
| 0.1 | 0.1 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 | 3.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 1.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.1 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 | 0.1 | GO:0014719 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.1 | 2.0 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.1 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 | 0.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 | 0.1 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 | 0.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.1 | 0.3 | GO:1904616 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.1 | 1.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 0.5 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 | 0.8 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.1 | 1.7 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.1 | 0.7 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.1 | 0.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 | 0.9 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.1 | 0.6 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.1 | 0.2 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.1 | 0.9 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) negative regulation of necrotic cell death(GO:0060547) |
| 0.1 | 1.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 0.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.1 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.1 | 0.3 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
| 0.1 | 0.7 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
| 0.1 | 1.4 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.1 | 0.7 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
| 0.1 | 0.9 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 0.3 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 | 0.3 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
| 0.1 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.1 | 0.3 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.1 | 0.6 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.1 | 0.1 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 | 0.1 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.1 | 0.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 0.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 | 2.5 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 | 2.0 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.1 | 1.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
| 0.1 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 | 0.5 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 0.1 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 | 0.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 | 1.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 0.7 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.1 | 0.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.1 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 | 1.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 0.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 | 0.1 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.1 | 7.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 | 0.2 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.2 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.1 | 0.4 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 | 3.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 | 4.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 | 0.3 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.1 | 0.1 | GO:0007611 | learning or memory(GO:0007611) |
| 0.1 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 0.5 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.1 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.1 | 0.4 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 | 0.2 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
| 0.1 | 0.1 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 0.1 | 1.2 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 0.4 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 | 1.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 0.4 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 0.3 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.1 | 1.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
| 0.1 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 0.4 | GO:1902661 | positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.1 | 0.2 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 | 0.1 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.1 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
| 0.1 | 0.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 0.1 | GO:1901655 | cellular response to ketone(GO:1901655) |
| 0.1 | 1.1 | GO:1902590 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.1 | 0.5 | GO:0033483 | gas homeostasis(GO:0033483) |
| 0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.1 | 0.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.1 | 0.3 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
| 0.1 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.1 | 0.3 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 | 0.2 | GO:0021983 | pituitary gland development(GO:0021983) |
| 0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 | 0.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.5 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
| 0.1 | 0.5 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.1 | 0.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 1.7 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 2.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 0.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 | 0.5 | GO:1904124 | mammary gland fat development(GO:0060611) mammary duct terminal end bud growth(GO:0060763) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) regulation of response to macrophage colony-stimulating factor(GO:1903969) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of glial cell migration(GO:1903977) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 0.1 | 1.5 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.1 | 1.9 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 6.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 0.2 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 0.9 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.2 | GO:0070142 | synaptic vesicle budding(GO:0070142) |
| 0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.1 | 0.8 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.1 | 1.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 | 0.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 4.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 0.4 | GO:0034959 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 | 0.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.5 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 | 0.5 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.1 | 0.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 | 0.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
| 0.1 | 0.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 0.5 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.1 | 0.4 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
| 0.1 | 0.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 1.3 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 3.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.1 | 1.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.1 | 0.2 | GO:0007135 | meiosis II(GO:0007135) |
| 0.1 | 0.3 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 0.2 | GO:0072171 | mesonephric tubule morphogenesis(GO:0072171) |
| 0.1 | 3.1 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 | 0.2 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
| 0.1 | 0.9 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
| 0.1 | 0.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 0.1 | 0.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.1 | 0.6 | GO:0048483 | autonomic nervous system development(GO:0048483) |
| 0.1 | 0.1 | GO:0007614 | short-term memory(GO:0007614) |
| 0.1 | 0.3 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.1 | 0.3 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.1 | 0.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 0.3 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 0.2 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.1 | 0.4 | GO:0016045 | detection of bacterium(GO:0016045) |
| 0.1 | 0.3 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 | 0.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.1 | 1.2 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.1 | 0.5 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.1 | 0.1 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
| 0.1 | 1.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 0.2 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
| 0.1 | 1.8 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.1 | 0.2 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.1 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
| 0.1 | 0.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 0.5 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.1 | 0.2 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.1 | 0.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.1 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 | 1.0 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 0.2 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
| 0.1 | 0.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
| 0.1 | 4.0 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.1 | 0.3 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.1 | 1.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 0.2 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 | 0.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
| 0.1 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.1 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.1 | 0.8 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.1 | 0.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 0.5 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.1 | 0.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.1 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.4 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 | 0.5 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 | 0.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 | 0.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.1 | 0.3 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
| 0.1 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
| 0.1 | 0.9 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 | 0.2 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
| 0.1 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.1 | 0.1 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
| 0.1 | 0.2 | GO:0042311 | vasodilation(GO:0042311) |
| 0.1 | 0.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.1 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.1 | 0.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.1 | 0.1 | GO:0051801 | cytolysis by symbiont of host cells(GO:0001897) cytolysis in other organism involved in symbiotic interaction(GO:0051801) |
| 0.1 | 0.1 | GO:0045995 | regulation of embryonic development(GO:0045995) |
| 0.1 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
| 0.1 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.1 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.1 | 0.9 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.3 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
| 0.1 | 0.4 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.1 | 0.6 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 1.1 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.1 | GO:0010948 | negative regulation of cell cycle process(GO:0010948) |
| 0.1 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 0.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 | 0.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.1 | 2.3 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 | 0.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 1.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.1 | 0.3 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
| 0.1 | 0.1 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 0.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.1 | 1.9 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 0.3 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 | 0.2 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.1 | 1.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.1 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 0.7 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 0.1 | 0.7 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 1.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.1 | 1.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 0.5 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 | 0.1 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 | 0.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.1 | 2.8 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.1 | 1.9 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.1 | 1.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 2.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 0.6 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.1 | 0.3 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.1 | 0.9 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
| 0.1 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 0.2 | GO:0007320 | insemination(GO:0007320) |
| 0.1 | 0.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 | 1.9 | GO:0046039 | GTP metabolic process(GO:0046039) |
| 0.1 | 0.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.1 | 0.4 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
| 0.1 | 0.1 | GO:0001756 | somitogenesis(GO:0001756) |
| 0.1 | 0.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 0.1 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.1 | 0.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 1.3 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.1 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.1 | 0.6 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.1 | 0.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.1 | 3.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.1 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.1 | 2.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.1 | 0.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.1 | 1.4 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 0.2 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 0.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.1 | 0.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 | 0.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.1 | 1.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 0.1 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.1 | 0.5 | GO:0042148 | meiotic DNA recombinase assembly(GO:0000707) strand invasion(GO:0042148) |
| 0.1 | 1.7 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.2 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 | 0.6 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.1 | 0.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 | 0.4 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.1 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 0.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.1 | 0.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.1 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.1 | 0.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.1 | 0.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 3.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 0.4 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.1 | 0.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.1 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 | 1.0 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
| 0.1 | 0.5 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 | 0.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 0.4 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.1 | 0.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 1.1 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.1 | 0.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.1 | 0.2 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
| 0.1 | 4.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 0.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.1 | 0.7 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.1 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
| 0.1 | 0.3 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) |
| 0.1 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 0.1 | GO:0031100 | organ regeneration(GO:0031100) |
| 0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.0 | 0.3 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
| 0.0 | 0.3 | GO:0042440 | pigment metabolic process(GO:0042440) |
| 0.0 | 0.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.0 | 0.0 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.0 | 0.3 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.0 | 0.2 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.0 | 2.2 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
| 0.0 | 0.4 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 | 0.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.0 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 0.0 | 0.1 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
| 0.0 | 0.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.0 | 0.1 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.0 | 0.2 | GO:0060324 | face development(GO:0060324) |
| 0.0 | 0.3 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.0 | 0.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.0 | 0.3 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.0 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.0 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.0 | 0.4 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.0 | 0.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.0 | 0.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 | 0.1 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) establishment of mitochondrion localization(GO:0051654) |
| 0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.0 | 0.0 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
| 0.0 | 0.6 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 0.0 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 | 1.7 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.0 | 0.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.0 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.0 | 0.3 | GO:0032196 | transposition(GO:0032196) |
| 0.0 | 0.3 | GO:0071383 | cellular response to steroid hormone stimulus(GO:0071383) |
| 0.0 | 0.0 | GO:0016137 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
| 0.0 | 1.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.0 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.0 | 3.6 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
| 0.0 | 0.1 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
| 0.0 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 | 0.1 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 | 0.8 | GO:0060402 | cytosolic calcium ion transport(GO:0060401) calcium ion transport into cytosol(GO:0060402) |
| 0.0 | 0.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 | 0.0 | GO:0021548 | pons development(GO:0021548) |
| 0.0 | 0.1 | GO:0007032 | endosome organization(GO:0007032) |
| 0.0 | 0.2 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.0 | 0.1 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.0 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.0 | 0.0 | GO:0016571 | histone methylation(GO:0016571) |
| 0.0 | 0.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.0 | 0.7 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 | 0.0 | GO:0010628 | positive regulation of gene expression(GO:0010628) |
| 0.0 | 0.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 | 0.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.0 | 0.2 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.0 | 0.0 | GO:0072678 | T cell migration(GO:0072678) |
| 0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.0 | 0.2 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.0 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 0.0 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.0 | 0.5 | GO:0034332 | adherens junction organization(GO:0034332) |
| 0.0 | 0.2 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.0 | 0.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.0 | 0.5 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.0 | 0.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.0 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 | 0.0 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
| 0.0 | 0.4 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
| 0.0 | 0.0 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 0.0 | 0.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
| 0.0 | 0.6 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
| 0.0 | 0.1 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.0 | 0.3 | GO:0006598 | polyamine catabolic process(GO:0006598) |
| 0.0 | 0.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.0 | 0.0 | GO:0055081 | anion homeostasis(GO:0055081) |
| 0.0 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.0 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.0 | 0.3 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.0 | 0.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 | 0.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.0 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 0.0 | 0.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 0.1 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
| 0.0 | 3.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.0 | 0.1 | GO:0007405 | neuroblast proliferation(GO:0007405) |
| 0.0 | 0.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.0 | 0.6 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.0 | 1.6 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 | 0.1 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.0 | 0.4 | GO:0048854 | brain morphogenesis(GO:0048854) |
| 0.0 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.0 | 0.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 | 0.2 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
| 0.0 | 1.1 | GO:0006096 | glycolytic process(GO:0006096) |
| 0.0 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.0 | 0.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 | 0.2 | GO:0099518 | vesicle cytoskeletal trafficking(GO:0099518) |
| 0.0 | 0.3 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 0.0 | 0.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.0 | 0.1 | GO:0030595 | leukocyte chemotaxis(GO:0030595) |
| 0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.0 | 0.1 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 0.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.0 | 0.1 | GO:0061589 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.0 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.0 | 0.2 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.0 | 0.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 | 0.1 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.0 | 0.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.0 | 0.1 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.0 | 0.1 | GO:0051048 | negative regulation of secretion(GO:0051048) |
| 0.0 | 0.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.0 | 0.6 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 | 0.6 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.0 | 0.3 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.0 | 0.0 | GO:0099637 | neurotransmitter receptor transport(GO:0099637) |
| 0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.0 | 0.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.0 | 0.5 | GO:0019674 | NAD metabolic process(GO:0019674) |
| 0.0 | 0.1 | GO:0021517 | ventral spinal cord development(GO:0021517) |
| 0.0 | 0.4 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
| 0.0 | 0.2 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.0 | 0.0 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.0 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.0 | 0.1 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
| 0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 | 0.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 0.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.0 | 0.0 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
| 0.0 | 0.1 | GO:0060348 | bone development(GO:0060348) |
| 0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.0 | 0.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.1 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.0 | 0.1 | GO:0042330 | chemotaxis(GO:0006935) taxis(GO:0042330) |
| 0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.0 | 0.3 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.0 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.0 | 0.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 | 0.2 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 0.1 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.0 | 0.3 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.0 | 0.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 | 0.0 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
| 0.0 | 0.0 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 | 0.1 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.0 | 0.1 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
| 0.0 | 0.0 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.1 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
| 0.0 | 0.0 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
| 0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 0.0 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
| 0.0 | 0.2 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) regulation of muscle hypertrophy(GO:0014743) |
| 0.0 | 1.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.0 | 0.1 | GO:0048753 | pigment granule organization(GO:0048753) |
| 0.0 | 0.7 | GO:0043486 | histone exchange(GO:0043486) |
| 0.0 | 0.2 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
| 0.0 | 0.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.0 | 0.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 0.0 | 0.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.0 | 0.2 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 | 0.0 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
| 0.0 | 0.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.0 | 0.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 0.2 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 | 0.0 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
| 0.0 | 0.1 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.0 | 0.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.0 | 0.0 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.0 | 0.0 | GO:0042770 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) signal transduction in response to DNA damage(GO:0042770) |
| 0.0 | 0.1 | GO:0035904 | aorta development(GO:0035904) |
| 0.0 | 0.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
| 0.0 | 0.0 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
| 0.0 | 0.0 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.0 | 0.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 | 0.9 | GO:0007565 | female pregnancy(GO:0007565) |
| 0.0 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 | 0.0 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.0 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.0 | 0.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.0 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.6 | 53.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 2.5 | 7.5 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 1.9 | 5.7 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 1.7 | 6.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 1.4 | 5.5 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 1.3 | 10.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 1.2 | 7.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.2 | 10.9 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 1.2 | 9.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 1.2 | 7.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 1.1 | 10.2 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 1.1 | 3.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 1.1 | 12.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.0 | 4.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 1.0 | 4.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 1.0 | 4.0 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 1.0 | 3.0 | GO:0031523 | Myb complex(GO:0031523) |
| 1.0 | 1.0 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
| 1.0 | 2.9 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 0.9 | 2.8 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.9 | 4.6 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.9 | 3.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.9 | 3.6 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.9 | 22.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.9 | 2.7 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.9 | 0.9 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.9 | 9.4 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.8 | 3.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.8 | 15.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.8 | 0.8 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.8 | 13.1 | GO:0008091 | spectrin(GO:0008091) |
| 0.8 | 3.1 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.8 | 0.8 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.8 | 2.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.8 | 2.3 | GO:0044393 | microspike(GO:0044393) |
| 0.8 | 4.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.8 | 0.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 0.8 | 13.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.7 | 5.9 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.7 | 2.9 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.7 | 0.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 0.7 | 4.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.7 | 3.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.7 | 2.0 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.6 | 1.9 | GO:0000806 | Y chromosome(GO:0000806) |
| 0.6 | 3.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.6 | 3.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.6 | 5.6 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.6 | 1.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.6 | 0.6 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.6 | 1.2 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.6 | 4.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.6 | 2.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.6 | 2.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.6 | 15.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.6 | 2.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.6 | 2.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.6 | 7.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.6 | 2.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.5 | 3.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.5 | 0.5 | GO:0043196 | varicosity(GO:0043196) |
| 0.5 | 1.6 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.5 | 2.2 | GO:0031417 | NatC complex(GO:0031417) |
| 0.5 | 1.6 | GO:1990923 | PET complex(GO:1990923) |
| 0.5 | 2.6 | GO:0035838 | growing cell tip(GO:0035838) |
| 0.5 | 2.0 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.5 | 3.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.5 | 2.0 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.5 | 2.5 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.5 | 2.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.5 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.5 | 31.5 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.5 | 3.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.5 | 2.4 | GO:0032449 | CBM complex(GO:0032449) |
| 0.5 | 1.9 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.5 | 0.9 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.5 | 4.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.5 | 0.9 | GO:0031045 | dense core granule(GO:0031045) |
| 0.4 | 1.7 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.4 | 2.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.4 | 1.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.4 | 0.4 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.4 | 0.4 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.4 | 4.1 | GO:0000796 | condensin complex(GO:0000796) |
| 0.4 | 2.1 | GO:0051286 | cell tip(GO:0051286) |
| 0.4 | 1.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.4 | 3.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.4 | 2.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.4 | 6.5 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.4 | 5.7 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.4 | 2.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.4 | 0.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.4 | 3.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.4 | 1.5 | GO:0055087 | Ski complex(GO:0055087) |
| 0.4 | 1.2 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.4 | 2.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.4 | 3.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.4 | 2.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.4 | 1.1 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.4 | 2.6 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.4 | 1.8 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.4 | 2.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.4 | 3.5 | GO:0043219 | lateral loop(GO:0043219) |
| 0.3 | 0.3 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 0.3 | 8.7 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.3 | 1.0 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.3 | 5.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.3 | 2.0 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.3 | 1.3 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.3 | 0.3 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.3 | 6.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.3 | 1.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.3 | 1.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.3 | 1.3 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 0.3 | 1.6 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.3 | 0.6 | GO:1990393 | 3M complex(GO:1990393) |
| 0.3 | 2.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.3 | 1.2 | GO:1990742 | microvesicle(GO:1990742) |
| 0.3 | 5.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.3 | 5.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.3 | 7.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.3 | 1.2 | GO:0070938 | contractile ring(GO:0070938) |
| 0.3 | 6.3 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.3 | 4.5 | GO:0045180 | basal cortex(GO:0045180) |
| 0.3 | 1.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.3 | 1.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.3 | 1.8 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.3 | 3.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.3 | 4.7 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.3 | 3.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 5.6 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.3 | 12.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.3 | 4.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.3 | 1.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.3 | 2.0 | GO:0033503 | HULC complex(GO:0033503) |
| 0.3 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.3 | 1.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.3 | 2.7 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.3 | 10.0 | GO:0030673 | axolemma(GO:0030673) |
| 0.3 | 4.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.3 | 1.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.3 | 1.1 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.3 | 1.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.3 | 1.9 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.3 | 2.1 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.3 | 1.3 | GO:0044308 | axonal spine(GO:0044308) |
| 0.3 | 0.3 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.3 | 8.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.3 | 2.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 1.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.3 | 1.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.3 | 1.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 8.4 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.3 | 3.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.3 | 1.0 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.3 | 5.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.3 | 1.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.3 | 1.0 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.3 | 1.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.2 | 0.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.2 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.2 | 5.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.2 | 1.2 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.2 | 2.7 | GO:0043203 | axon hillock(GO:0043203) |
| 0.2 | 2.2 | GO:0032059 | bleb(GO:0032059) |
| 0.2 | 1.2 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.2 | 0.2 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.2 | 1.9 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.2 | 1.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.2 | 0.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.2 | 0.7 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.2 | 2.1 | GO:0005638 | lamin filament(GO:0005638) |
| 0.2 | 1.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.2 | 2.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.2 | 3.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.2 | 2.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 1.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 23.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.2 | 2.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.2 | 0.7 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.2 | 18.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.2 | 2.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.2 | 1.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.2 | 19.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.2 | 5.6 | GO:0046930 | pore complex(GO:0046930) |
| 0.2 | 2.5 | GO:0098644 | complex of collagen trimers(GO:0098644) |
| 0.2 | 2.0 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 11.9 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.2 | 0.2 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.2 | 2.2 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 0.2 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.2 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
| 0.2 | 4.5 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.2 | 1.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.2 | 1.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.2 | 1.5 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.2 | 1.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.2 | 0.9 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.2 | 1.5 | GO:0071546 | pi-body(GO:0071546) |
| 0.2 | 0.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 5.8 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.2 | 3.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 1.7 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.2 | 4.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.2 | 0.4 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.2 | 0.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.2 | 0.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.2 | 1.6 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.2 | 2.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.2 | 0.2 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.2 | 0.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.2 | 0.8 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.2 | 3.8 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.2 | 1.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.2 | 1.2 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.2 | 1.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.2 | 0.6 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.2 | 1.6 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.2 | 1.2 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 0.6 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.2 | 20.9 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.2 | 0.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.2 | 2.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 1.4 | GO:0042825 | TAP complex(GO:0042825) |
| 0.2 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 0.6 | GO:0036024 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.2 | 22.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.2 | 1.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.2 | 6.3 | GO:0043034 | costamere(GO:0043034) |
| 0.2 | 0.6 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.2 | 1.3 | GO:0098589 | membrane region(GO:0098589) |
| 0.2 | 3.5 | GO:0010369 | chromocenter(GO:0010369) |
| 0.2 | 0.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.2 | 4.4 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 6.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.2 | 14.8 | GO:0005901 | caveola(GO:0005901) |
| 0.2 | 2.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.2 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.2 | 0.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.2 | 0.4 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.2 | 4.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.2 | 1.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 2.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.2 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
| 0.2 | 0.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.2 | 1.2 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.2 | 1.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.2 | 0.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.2 | 1.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.2 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.2 | 8.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.2 | 1.9 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.2 | 2.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 3.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.2 | 1.7 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.2 | 0.8 | GO:0005883 | neurofilament(GO:0005883) |
| 0.2 | 5.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 1.5 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.2 | 0.8 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.2 | 1.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 7.3 | GO:0002102 | podosome(GO:0002102) |
| 0.2 | 0.7 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.2 | 2.1 | GO:0030478 | actin cap(GO:0030478) |
| 0.2 | 0.2 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.2 | 0.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.2 | 2.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.2 | 0.5 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.2 | 1.4 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.2 | 2.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.2 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 4.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.2 | 12.7 | GO:0005604 | basement membrane(GO:0005604) |
| 0.2 | 1.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
| 0.2 | 0.5 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.2 | 3.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.2 | 1.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.2 | 1.7 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.2 | 1.5 | GO:0033643 | host cell part(GO:0033643) |
| 0.2 | 1.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 0.5 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.2 | 0.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.2 | 0.8 | GO:0032021 | NELF complex(GO:0032021) |
| 0.2 | 2.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.2 | 4.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.2 | 1.1 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.4 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.1 | 0.4 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.1 | 1.0 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.1 | 0.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.1 | 1.5 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 1.0 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 0.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 77.7 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 2.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.1 | 4.9 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 0.1 | 0.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.1 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.1 | 5.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 0.4 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.1 | 1.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.1 | 2.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.1 | 2.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 0.4 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.1 | 8.9 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 6.5 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 0.5 | GO:0030424 | axon(GO:0030424) |
| 0.1 | 1.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.1 | 0.3 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.1 | 0.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 0.7 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.1 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.1 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.1 | 0.9 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.1 | 0.4 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.1 | 1.4 | GO:0005694 | chromosome(GO:0005694) |
| 0.1 | 1.8 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.9 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 0.1 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
| 0.1 | 10.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 1.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.1 | 0.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.1 | 1.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.1 | 1.2 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 0.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.1 | 0.7 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 0.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 4.1 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.7 | GO:0031672 | A band(GO:0031672) |
| 0.1 | 0.7 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.1 | 4.7 | GO:0032420 | stereocilium(GO:0032420) |
| 0.1 | 1.6 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 1.0 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 0.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.1 | 1.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 14.8 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
| 0.1 | 178.2 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 7.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 1.1 | GO:0032797 | SMN complex(GO:0032797) |
| 0.1 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 11.6 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 0.4 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 3.1 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 0.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.1 | 1.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 0.2 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.1 | 1.9 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 0.9 | GO:0090543 | Flemming body(GO:0090543) |
| 0.1 | 0.1 | GO:1990752 | microtubule end(GO:1990752) |
| 0.1 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
| 0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 0.5 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 0.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 1.4 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.1 | 0.6 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.1 | 0.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.1 | 0.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.1 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.1 | 1.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 2.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 2.0 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 0.8 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 0.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.1 | 1.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 3.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 0.4 | GO:0031251 | PAN complex(GO:0031251) |
| 0.1 | 0.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 4.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 0.8 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.1 | 0.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.1 | 0.4 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 0.6 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.1 | 0.3 | GO:0000811 | GINS complex(GO:0000811) |
| 0.1 | 0.3 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.1 | 9.6 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.1 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 0.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.1 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.1 | 0.4 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.1 | 6.2 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.9 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.1 | 1.6 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 5.3 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.1 | 1.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 1.2 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 0.9 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 0.5 | GO:0097361 | CIA complex(GO:0097361) |
| 0.1 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.1 | 2.4 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 8.1 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 7.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 0.2 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.1 | 0.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 1.1 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 0.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 4.7 | GO:0031674 | I band(GO:0031674) |
| 0.1 | 6.5 | GO:0005912 | adherens junction(GO:0005912) |
| 0.1 | 17.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.1 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 0.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 1.7 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
| 0.1 | 1.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 0.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 0.8 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.1 | 10.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 0.2 | GO:0005940 | septin ring(GO:0005940) septin collar(GO:0032173) |
| 0.1 | 0.8 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 2.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.6 | GO:0005911 | cell-cell junction(GO:0005911) |
| 0.1 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 9.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 2.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 1.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.1 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.1 | 1.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 0.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 1.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 0.1 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 5.4 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.1 | 2.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 0.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 0.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.1 | 0.2 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.1 | 1.0 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.1 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 0.2 | GO:0044449 | contractile fiber part(GO:0044449) |
| 0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 0.5 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 0.2 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.1 | 0.6 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.1 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.0 | 0.2 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.0 | 0.7 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.0 | 0.1 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.0 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.8 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.0 | 0.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.0 | 0.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 0.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.0 | 1.5 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.0 | 0.9 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.0 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.0 | 0.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
| 0.0 | 0.1 | GO:0044753 | amphisome(GO:0044753) |
| 0.0 | 0.5 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.0 | 0.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.0 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 0.1 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.0 | 0.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.0 | 2.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.4 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.0 | 0.1 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.0 | 0.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.0 | 0.7 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.0 | 3.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
| 0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.0 | 0.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.0 | 1.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.7 | GO:0012506 | vesicle membrane(GO:0012506) |
| 0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 0.1 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.0 | 15.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.0 | 1.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.0 | 2.5 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 1.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.0 | 4.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.0 | 4.6 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 0.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.6 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 0.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.0 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.0 | 0.0 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 0.0 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
| 0.0 | 0.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 0.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.8 | GO:0009986 | cell surface(GO:0009986) |
| 0.0 | 0.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
| 0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.0 | 0.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.0 | 0.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.0 | 0.1 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 1.8 | GO:0015629 | actin cytoskeleton(GO:0015629) |
| 0.0 | 0.0 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.0 | 0.7 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.0 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.4 | 10.1 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 3.2 | 9.6 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 2.4 | 12.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 2.4 | 12.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 2.2 | 11.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 2.1 | 8.3 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 2.1 | 6.2 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 2.1 | 6.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 2.0 | 4.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 2.0 | 12.0 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 1.9 | 5.7 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 1.9 | 7.5 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 1.6 | 4.9 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 1.6 | 8.0 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 1.6 | 7.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 1.4 | 5.8 | GO:0008431 | vitamin E binding(GO:0008431) |
| 1.4 | 21.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 1.4 | 5.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 1.4 | 12.5 | GO:0043426 | MRF binding(GO:0043426) |
| 1.4 | 5.6 | GO:0030395 | lactose binding(GO:0030395) |
| 1.4 | 5.5 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 1.3 | 5.3 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 1.3 | 4.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 1.3 | 3.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 1.3 | 5.1 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 1.3 | 6.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 1.2 | 7.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 1.2 | 3.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.2 | 4.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 1.2 | 4.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 1.2 | 11.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 1.2 | 3.5 | GO:0050421 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 1.1 | 2.3 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 1.1 | 4.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 1.1 | 3.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 1.1 | 4.3 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 1.1 | 6.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 1.1 | 3.2 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 1.0 | 7.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 1.0 | 5.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 1.0 | 3.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 1.0 | 7.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 1.0 | 9.8 | GO:0042731 | PH domain binding(GO:0042731) |
| 1.0 | 2.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 1.0 | 6.9 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 1.0 | 4.8 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 1.0 | 4.8 | GO:0050436 | microfibril binding(GO:0050436) |
| 1.0 | 13.4 | GO:0031014 | troponin T binding(GO:0031014) |
| 1.0 | 5.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.9 | 4.7 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 0.9 | 5.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.9 | 3.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.9 | 2.8 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.9 | 5.5 | GO:0034618 | arginine binding(GO:0034618) |
| 0.9 | 5.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.9 | 2.7 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.9 | 5.3 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.9 | 2.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.9 | 10.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.9 | 7.7 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.8 | 5.9 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.8 | 14.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.8 | 3.3 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.8 | 2.5 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.8 | 3.3 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.8 | 3.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.8 | 5.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.8 | 4.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.8 | 6.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.8 | 2.4 | GO:0050072 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) m7G(5')pppN diphosphatase activity(GO:0050072) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.8 | 3.9 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.8 | 3.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.8 | 2.3 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.8 | 4.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.7 | 4.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.7 | 4.5 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.7 | 1.5 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
| 0.7 | 6.0 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.7 | 6.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.7 | 1.5 | GO:0070325 | low-density lipoprotein particle receptor binding(GO:0050750) lipoprotein particle receptor binding(GO:0070325) |
| 0.7 | 1.4 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 0.7 | 230.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.7 | 7.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.7 | 2.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 0.7 | 3.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.7 | 2.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.7 | 2.0 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.7 | 6.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.7 | 2.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.6 | 3.2 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.6 | 5.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.6 | 2.6 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.6 | 5.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.6 | 2.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.6 | 1.9 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.6 | 1.9 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 0.6 | 3.7 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.6 | 4.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.6 | 4.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.6 | 7.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.6 | 5.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.6 | 3.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.6 | 2.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.6 | 1.8 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.6 | 2.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.6 | 10.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.6 | 1.7 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.6 | 2.9 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.6 | 3.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.6 | 4.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.6 | 3.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.6 | 8.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.6 | 3.3 | GO:0042835 | BRE binding(GO:0042835) |
| 0.6 | 6.6 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.6 | 7.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.5 | 2.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.5 | 1.6 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 0.5 | 6.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.5 | 2.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.5 | 11.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.5 | 1.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.5 | 5.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.5 | 15.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.5 | 2.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.5 | 1.6 | GO:0016208 | AMP binding(GO:0016208) |
| 0.5 | 2.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.5 | 4.7 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.5 | 5.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.5 | 1.6 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.5 | 3.6 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.5 | 7.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.5 | 4.7 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.5 | 0.5 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.5 | 2.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.5 | 2.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.5 | 1.5 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.5 | 1.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.5 | 0.5 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.5 | 2.5 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.5 | 10.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.5 | 1.5 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.5 | 2.0 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.5 | 9.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.5 | 1.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.5 | 9.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.5 | 11.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.5 | 4.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.5 | 1.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.5 | 1.4 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.5 | 3.4 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.5 | 2.9 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.5 | 1.4 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.5 | 1.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.5 | 2.8 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.5 | 1.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.5 | 1.9 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.5 | 1.4 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.5 | 2.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.5 | 5.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.5 | 4.2 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.5 | 1.4 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
| 0.5 | 2.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.5 | 1.4 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.5 | 5.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.5 | 4.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.5 | 1.8 | GO:0004802 | transketolase activity(GO:0004802) |
| 0.5 | 1.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.4 | 1.3 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.4 | 1.8 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.4 | 9.4 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.4 | 0.4 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.4 | 4.0 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.4 | 6.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.4 | 1.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.4 | 1.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.4 | 0.9 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.4 | 1.3 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 0.4 | 1.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.4 | 2.1 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.4 | 3.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.4 | 2.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.4 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.4 | 1.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.4 | 1.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.4 | 1.3 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.4 | 2.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.4 | 1.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.4 | 5.8 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.4 | 3.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.4 | 1.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.4 | 2.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.4 | 1.2 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
| 0.4 | 1.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.4 | 1.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.4 | 1.2 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.4 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.4 | 2.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.4 | 2.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.4 | 0.8 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.4 | 6.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.4 | 1.2 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.4 | 0.4 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
| 0.4 | 2.0 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.4 | 1.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.4 | 1.2 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.4 | 3.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.4 | 1.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.4 | 1.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.4 | 0.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.4 | 0.8 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.4 | 0.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.4 | 1.1 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.4 | 4.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.4 | 2.3 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.4 | 1.1 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.4 | 4.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.4 | 7.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.4 | 1.9 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.4 | 1.5 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.4 | 3.4 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.4 | 14.2 | GO:0043236 | laminin binding(GO:0043236) |
| 0.4 | 7.1 | GO:0030546 | receptor activator activity(GO:0030546) |
| 0.4 | 0.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.4 | 1.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.4 | 3.0 | GO:0005497 | androgen binding(GO:0005497) |
| 0.4 | 5.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.4 | 0.4 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.4 | 1.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.4 | 4.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.4 | 2.9 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.4 | 0.7 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.4 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.4 | 1.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.4 | 16.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.4 | 2.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.4 | 1.8 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.4 | 1.1 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
| 0.4 | 5.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.3 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.3 | 1.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.3 | 0.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
| 0.3 | 1.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.3 | 1.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.3 | 3.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.3 | 3.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.3 | 1.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 1.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.3 | 1.0 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.3 | 3.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.3 | 4.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.3 | 0.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.3 | 1.7 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.3 | 2.0 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.3 | 7.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.3 | 1.0 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.3 | 2.3 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.3 | 4.6 | GO:0089720 | caspase binding(GO:0089720) |
| 0.3 | 2.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.3 | 3.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.3 | 1.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.3 | 2.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.3 | 1.3 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.3 | 3.6 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.3 | 1.0 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.3 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.3 | 6.7 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.3 | 0.6 | GO:0033265 | choline binding(GO:0033265) |
| 0.3 | 4.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.3 | 10.7 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.3 | 9.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.3 | 0.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.3 | 0.9 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.3 | 0.3 | GO:0000035 | acyl binding(GO:0000035) |
| 0.3 | 0.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.3 | 9.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.3 | 9.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.3 | 1.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.3 | 5.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.3 | 0.6 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.3 | 1.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.3 | 7.1 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.3 | 1.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.3 | 1.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.3 | 2.1 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.3 | 1.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.3 | 0.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.3 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.3 | 0.9 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.3 | 0.6 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.3 | 1.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.3 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.3 | 3.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.3 | 5.7 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.3 | 1.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.3 | 0.6 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.3 | 4.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.3 | 22.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.3 | 1.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.3 | 2.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.3 | 6.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.3 | 1.2 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.3 | 9.9 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.3 | 1.2 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.3 | 2.3 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.3 | 0.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.3 | 1.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.3 | 8.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.3 | 1.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.3 | 1.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.3 | 1.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.3 | 0.8 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.3 | 0.8 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.3 | 0.3 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.3 | 3.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.3 | 23.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.3 | 1.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.3 | 1.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.3 | 13.0 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.3 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.3 | 1.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.3 | 2.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.3 | 0.8 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.3 | 2.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.3 | 1.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.3 | 1.9 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.3 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.3 | 0.8 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.3 | 1.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.3 | 5.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.3 | 0.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.3 | 2.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.3 | 3.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.3 | 0.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.3 | 1.0 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
| 0.3 | 1.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.3 | 0.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.3 | 2.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.3 | 1.0 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.3 | 0.8 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.3 | 0.8 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.3 | 0.5 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.3 | 3.1 | GO:0008061 | chitin binding(GO:0008061) |
| 0.3 | 1.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.3 | 11.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.3 | 8.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.3 | 5.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.3 | 2.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
| 0.3 | 7.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.2 | 1.0 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 0.2 | 1.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.2 | 0.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.2 | 2.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.2 | 1.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.2 | 4.9 | GO:0019841 | retinol binding(GO:0019841) |
| 0.2 | 2.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.2 | 1.7 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.2 | 2.4 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.2 | 1.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.2 | 0.5 | GO:0070404 | NADH binding(GO:0070404) |
| 0.2 | 1.5 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.2 | 2.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.2 | 0.5 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.2 | 1.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.2 | 0.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.2 | 1.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.2 | 4.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.2 | 0.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.2 | 0.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.2 | 1.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.2 | 0.7 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.2 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.2 | 2.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.2 | 0.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.2 | 0.9 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.2 | 2.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 1.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.2 | 0.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.2 | 2.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.2 | 2.2 | GO:0046790 | virion binding(GO:0046790) |
| 0.2 | 2.2 | GO:0008201 | heparin binding(GO:0008201) |
| 0.2 | 2.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.2 | 1.1 | GO:0005536 | glucose binding(GO:0005536) |
| 0.2 | 3.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.2 | 0.9 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.2 | 1.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.2 | 5.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.2 | 0.7 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.2 | 4.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.2 | 1.1 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.2 | 1.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.2 | 1.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.2 | 0.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.2 | 0.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.2 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.2 | 3.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.2 | 1.1 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.2 | 2.4 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.2 | 1.7 | GO:0048185 | activin binding(GO:0048185) |
| 0.2 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.2 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.2 | 8.9 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.2 | 1.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.2 | 2.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.2 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.2 | 0.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.2 | 1.4 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.2 | 1.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 2.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.2 | 4.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.2 | 0.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.2 | 11.4 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 7.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.2 | 0.2 | GO:0015036 | protein disulfide oxidoreductase activity(GO:0015035) disulfide oxidoreductase activity(GO:0015036) |
| 0.2 | 6.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 1.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.2 | 1.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.2 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 2.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.2 | 1.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.2 | 3.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.2 | 0.6 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.2 | 1.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 0.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.2 | 2.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 0.6 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.2 | 1.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.2 | 0.9 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.2 | 1.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 1.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.2 | 2.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.2 | 1.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.2 | 5.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.2 | 1.8 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.2 | 2.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.2 | 1.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.2 | 1.5 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.2 | 5.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 3.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.2 | 0.5 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) ghrelin receptor binding(GO:0031768) |
| 0.2 | 0.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.2 | 0.5 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.2 | 2.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.2 | 0.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.2 | 2.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.2 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.2 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.2 | 0.7 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.2 | 2.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.2 | 1.1 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.2 | 1.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.2 | 1.6 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 1.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.2 | 0.5 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.2 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.2 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 1.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.2 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 0.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.2 | 0.9 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.2 | 0.5 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.2 | 1.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.2 | 8.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.2 | 1.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.2 | 0.2 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 0.2 | 2.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.2 | 0.5 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.2 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.2 | 1.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.2 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
| 0.2 | 1.3 | GO:0060090 | binding, bridging(GO:0060090) |
| 0.2 | 0.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.2 | 1.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.2 | 3.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.2 | 1.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.2 | 0.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.2 | 0.5 | GO:0003724 | RNA helicase activity(GO:0003724) |
| 0.2 | 0.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.2 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.2 | 0.8 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.2 | 1.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.2 | 1.5 | GO:0035240 | dopamine binding(GO:0035240) |
| 0.2 | 0.8 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.2 | 3.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 1.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.2 | 0.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
| 0.2 | 0.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.2 | 29.1 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.2 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.2 | 0.5 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.2 | 3.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.2 | 0.6 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
| 0.2 | 0.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.2 | 2.8 | GO:0008233 | peptidase activity(GO:0008233) |
| 0.2 | 1.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 0.5 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.2 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.2 | 0.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.2 | 1.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.2 | 3.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.2 | 3.6 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.2 | 1.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.2 | 2.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.2 | 3.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 0.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.2 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 5.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.2 | 7.0 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.2 | 0.5 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.2 | 0.5 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.2 | 0.5 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.2 | 0.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.1 | 0.4 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.1 | 2.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.3 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.1 | 1.9 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.1 | 0.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.1 | 2.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 1.5 | GO:0036310 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
| 0.1 | 0.3 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
| 0.1 | 0.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.1 | 1.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 1.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 3.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.1 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 3.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 0.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.1 | 9.4 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.1 | 2.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 2.0 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.1 | 0.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
| 0.1 | 4.0 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.7 | GO:0042806 | fucose binding(GO:0042806) |
| 0.1 | 1.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.3 | GO:0016247 | channel regulator activity(GO:0016247) |
| 0.1 | 2.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 0.3 | GO:0001653 | peptide receptor activity(GO:0001653) G-protein coupled peptide receptor activity(GO:0008528) |
| 0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.1 | 1.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 0.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.1 | 0.4 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.1 | 0.6 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.1 | 0.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.6 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 1.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.1 | 0.5 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.1 | 0.9 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.1 | 14.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 1.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 0.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
| 0.1 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.1 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 14.3 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 1.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 0.5 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 0.1 | 0.5 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.1 | 0.1 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.1 | 1.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 4.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.4 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.1 | 0.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.1 | 0.5 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.1 | 2.6 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
| 0.1 | 13.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 1.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.1 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 0.4 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.1 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.1 | 1.6 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.1 | 0.9 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.1 | 1.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 0.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.1 | 0.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
| 0.1 | 3.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.9 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.1 | 5.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 5.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 1.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.1 | 1.5 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.1 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.1 | 1.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.1 | 0.5 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.1 | 5.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.1 | 0.4 | GO:0008238 | exopeptidase activity(GO:0008238) |
| 0.1 | 0.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.1 | 0.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 0.4 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.1 | 11.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 0.6 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 0.1 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 0.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.1 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 1.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.1 | 0.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.1 | 2.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.1 | 0.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 13.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 1.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 0.1 | GO:0001221 | transcription cofactor binding(GO:0001221) transcription coactivator binding(GO:0001223) |
| 0.1 | 0.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.1 | 0.3 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.1 | 1.8 | GO:0005549 | odorant binding(GO:0005549) |
| 0.1 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.4 | GO:0030619 | U1 snRNA binding(GO:0030619) |
| 0.1 | 1.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 10.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 3.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 0.6 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.1 | 0.1 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
| 0.1 | 5.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 0.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.1 | 5.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 0.2 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.1 | 0.5 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.1 | 0.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.1 | 0.4 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.1 | 0.6 | GO:0016972 | thiol oxidase activity(GO:0016972) |
| 0.1 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.1 | 0.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 1.2 | GO:0002039 | p53 binding(GO:0002039) |
| 0.1 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.1 | 0.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.1 | 0.5 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.1 | 4.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.1 | 0.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.1 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 0.9 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
| 0.1 | 0.4 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.1 | 1.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 8.0 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.1 | 0.4 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.1 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 0.1 | GO:0016531 | copper chaperone activity(GO:0016531) copper-dependent protein binding(GO:0032767) |
| 0.1 | 0.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.1 | 0.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.1 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.6 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.1 | 2.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 0.2 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.1 | 0.3 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.1 | 0.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 2.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 8.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 0.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.1 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 0.5 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 0.3 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 0.1 | 0.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
| 0.1 | 0.8 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.1 | 4.4 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.1 | 0.3 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.1 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.1 | 0.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.1 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.1 | 0.3 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.1 | 1.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.1 | 2.0 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
| 0.1 | 0.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 2.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.1 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.1 | 30.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.1 | 0.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.1 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 2.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 1.5 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.1 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 0.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 0.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.1 | 0.4 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.1 | 0.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.1 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.1 | 1.6 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 0.2 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
| 0.1 | 0.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.1 | 0.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.1 | 0.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.1 | 0.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.1 | 0.4 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.1 | 4.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.1 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.1 | 3.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.1 | 6.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 0.1 | GO:0015216 | purine nucleotide transmembrane transporter activity(GO:0015216) |
| 0.1 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 0.3 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.1 | 0.2 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 0.1 | 0.3 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.1 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.7 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 1.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.1 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 1.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 1.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.1 | 0.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.1 | 0.4 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.1 | 0.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.1 | 0.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.1 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.1 | 0.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.1 | 0.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 0.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.1 | 0.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.1 | 0.4 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.1 | 1.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 1.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 1.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.1 | 0.5 | GO:0051213 | dioxygenase activity(GO:0051213) |
| 0.1 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 1.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 0.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.1 | 0.2 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
| 0.1 | 1.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 0.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
| 0.1 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.1 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.1 | 1.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.1 | 1.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 0.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 1.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.2 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.1 | 0.2 | GO:0004629 | phospholipase C activity(GO:0004629) |
| 0.1 | 0.2 | GO:0001855 | complement component C4b binding(GO:0001855) complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 0.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 0.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.0 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 0.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.0 | 4.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.0 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.0 | 0.4 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
| 0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.0 | 4.0 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.0 | 0.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.0 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.7 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 3.4 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 1.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 1.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.0 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.0 | 0.1 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.0 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 0.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.0 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 0.0 | 0.3 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.0 | 0.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.0 | 0.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.0 | 1.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.0 | 0.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.1 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.0 | 10.6 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 20.2 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.0 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.0 | 2.8 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
| 0.0 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.0 | 0.1 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 0.0 | 0.1 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.0 | 3.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.1 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.0 | 3.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.0 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.0 | 0.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 0.1 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.0 | 0.0 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.0 | 0.5 | GO:0031005 | filamin binding(GO:0031005) |
| 0.0 | 0.5 | GO:0016248 | channel inhibitor activity(GO:0016248) |
| 0.0 | 0.4 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) SAM domain binding(GO:0032093) |
| 0.0 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.0 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.0 | 0.8 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.0 | 0.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.0 | 0.1 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.0 | 0.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.0 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.0 | 0.1 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.0 | 0.1 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.0 | 0.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.0 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.0 | 0.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.0 | 0.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 0.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.0 | 0.1 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.0 | 4.8 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 0.6 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.0 | 0.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.0 | 0.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.0 | 0.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.0 | 0.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
| 0.0 | 0.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.0 | 1.3 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.0 | 0.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 1.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.1 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.0 | 0.0 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.0 | 0.2 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.0 | 0.4 | GO:0019838 | growth factor binding(GO:0019838) |
| 0.0 | 0.3 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.0 | 0.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.2 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 0.0 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.0 | 0.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.0 | 0.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.0 | 0.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 0.0 | 0.0 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
| 0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
| 0.0 | 0.2 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 104.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.9 | 12.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.7 | 21.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.7 | 15.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.6 | 11.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.6 | 41.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.6 | 16.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.5 | 5.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.5 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.5 | 1.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.5 | 3.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.5 | 31.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.5 | 3.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.5 | 12.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.4 | 12.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.4 | 22.5 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.4 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.4 | 8.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.4 | 13.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.4 | 7.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.4 | 7.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.4 | 2.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.3 | 28.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.3 | 10.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.3 | 6.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.3 | 10.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.3 | 4.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 4.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.3 | 11.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.3 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.3 | 9.3 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.3 | 4.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.3 | 9.0 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.3 | 9.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.3 | 14.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.3 | 81.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.3 | 1.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 2.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.2 | 8.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.2 | 1.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.2 | 6.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.2 | 3.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.2 | 2.9 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.2 | 8.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 7.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 4.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.2 | 11.9 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.2 | 4.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.2 | 0.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.2 | 3.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 3.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.2 | 4.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 8.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.2 | 2.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.2 | 6.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.2 | 3.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.2 | 2.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.2 | 4.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.2 | 5.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.2 | 4.1 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.2 | 3.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.2 | 6.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.2 | 41.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.2 | 1.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.2 | 1.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.2 | 3.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.2 | 10.0 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.2 | 2.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 2.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 4.9 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 1.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 2.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 2.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 1.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 1.4 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 2.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 7.0 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 1.1 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 46.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 3.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.1 | 5.0 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 6.8 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 8.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 1.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 2.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 0.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 2.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 0.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 1.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 0.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 4.4 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 1.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 2.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 0.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.0 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 0.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 0.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 1.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 1.4 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.0 | 1.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 1.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 0.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 1.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.0 | 0.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 1.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.9 | 23.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.9 | 13.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.8 | 15.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.7 | 17.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.7 | 0.7 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.7 | 9.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.7 | 0.7 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
| 0.7 | 12.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.6 | 12.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.6 | 15.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.6 | 6.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.5 | 20.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.5 | 15.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.5 | 13.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.5 | 25.4 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.5 | 33.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.5 | 3.2 | REACTOME SEMAPHORIN INTERACTIONS | Genes involved in Semaphorin interactions |
| 0.5 | 6.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.5 | 14.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.4 | 10.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.4 | 4.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.4 | 13.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.4 | 5.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.4 | 2.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.4 | 31.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.4 | 15.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.4 | 10.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.4 | 6.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.4 | 3.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.4 | 5.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.4 | 2.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.4 | 16.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.4 | 8.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.4 | 2.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.4 | 10.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.4 | 1.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.4 | 7.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.4 | 0.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.4 | 9.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.3 | 4.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.3 | 15.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.3 | 7.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.3 | 23.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.3 | 7.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.3 | 6.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.3 | 3.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.3 | 5.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.3 | 5.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.3 | 5.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.3 | 1.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.3 | 9.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.3 | 13.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.3 | 10.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.3 | 27.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.3 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.3 | 5.7 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.3 | 1.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.3 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.3 | 14.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.3 | 5.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.3 | 4.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.3 | 1.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.3 | 3.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.3 | 4.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.3 | 5.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.3 | 14.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.2 | 6.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 6.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 1.9 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.2 | 4.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.2 | 5.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.2 | 1.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.2 | 6.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 1.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.2 | 0.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.2 | 4.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 8.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 6.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 3.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.2 | 4.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.2 | 8.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.2 | 0.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.2 | 4.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.2 | 6.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.2 | 3.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.2 | 2.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.2 | 5.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.2 | 3.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.2 | 1.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.2 | 1.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.2 | 3.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 5.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 2.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.2 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.2 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.2 | 20.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.2 | 2.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.2 | 11.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.2 | 3.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.2 | 1.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 2.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.2 | 4.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.2 | 2.2 | REACTOME OPSINS | Genes involved in Opsins |
| 0.2 | 3.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.2 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.2 | 4.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.2 | 1.1 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.2 | 8.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.2 | 2.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.2 | 20.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.2 | 11.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 4.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.1 | 2.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.1 | 3.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.1 | 1.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 0.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.1 | 2.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 5.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 4.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.1 | 1.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 1.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 2.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 0.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.1 | 2.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 0.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.1 | 2.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 2.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.1 | 2.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 1.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.1 | 4.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 2.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.1 | 1.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.1 | 3.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 0.2 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
| 0.1 | 7.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 0.6 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
| 0.1 | 3.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 4.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 6.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 1.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 10.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 1.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.1 | 5.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.1 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 0.8 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.1 | 3.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 2.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 1.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 1.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.1 | 1.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 2.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.1 | 1.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 3.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 1.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 1.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 5.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 3.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 2.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 0.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.1 | 2.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 2.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 4.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 1.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 1.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 6.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 1.1 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
| 0.1 | 0.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.1 | 1.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 15.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.1 | 1.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.1 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 3.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 1.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.1 | 0.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 2.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 0.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.0 | 0.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.0 | 3.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 0.0 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 0.3 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.0 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 0.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 0.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 3.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 1.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 2.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 2.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.0 | 1.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.0 | 0.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.0 | 1.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.0 | 4.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.0 | 0.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.0 | 0.3 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.0 | 0.9 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.0 | 0.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |